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FAMILY CHEMOPROPHYLAXIS IN STREPTOCOCCAL PHARYNGITIS帝
P重elimina重y Study
GERALD HASS, M.D.,
I悪霊詩誌書誌嵩a窪‡ :
COCCal disease are important factors in the
PreVention of nonsuppurative sequelae of this
COndition.1 The foIIowing report describes a
Study in the home treatment of streptococcal
Pharyngitis carried out during the first five
months of 1962, Within the framework of the
Home Medical Service of Massachusetts Me_
morial Hospitals. This Service provides
domiciliary medical care to the indigent pop-
ulation in part of the South End and adja-
Cent POrtion of Roxbury in Boston. The
Care is provided by fourth-year medical stu-
dents under the supervision of the staff of
the Department of Preventive Medicine of
Boston University SchooI of Medicine and
the Home Medical Service, Division of
Health Conservation, Massachusetts Memo-
rial Hospitals.2
It has become well recognized that study
Of the patient in his home glVeS a mOre aC-
Curate PICture Of this common disease than
Can be obtained otherwise. Studies invoIving
large military populations, SChool pepula-
tions) and patients seen at outpatient depart一
叩rom the Department of Preventive Medicine,
Boston University School of Medicine, and the
Home Medical Service, Division of Health Con-
§erVation, Ma§§aChusetts Memorial Hospitals, Bos-
ton University Medical CenteI‘.
†Senior teaching fellow in preventive medicine,
Boston University School of Medicine; aSSistant
resident, Home Medical Service, Division of Health
Conservation, Massachusetts Memorial Hospitals.
in Home Treatment
B.S. (LoND・), D.C.H.†
ments have contributed valuable information
to this fieId.3’4　Since the home is the more
usual envi onment for the occurrence and
management of streptococcal illness, domicil-
1a y Care) SuPPOrted by adequate laboratory
resources) PrOVides the most meaningful data
in this context.
Im,e∫tigation of !he巾γead of Jlγepiococcal
di∫eaJeわ/amilie∫
Throat swabs were obtained from all fam_
ily contacts of known cases of streptococcal
Pharyngitis. Typing of the Group A strepto-
COCCuS from both primary and secondary
CaSeS PrOVided evidence of the extent of
SPread of the same organism, Within the fam-
ily group'
Ez,alαation of !he郷e of /amily chemopγ0-
phyla読
Family con ac s with negative throat cul-
tures were glV n a three-day prophylactic
COurSe Of penicillin or erythromycin. This
Period of prophylaxis was chosen since treat-
ment of the origin l case of pharyngitis usu-
ally renders the paticnt noninfectious after
three days and, therefore, Should prevent
tra smission of the organism to the family
COntaCtS. Evidence of successful prophylaxis
WaS Obtained by later cultures on these pre-
Viously negative contacts.
Follow-uP Cultures of patients with positive
throat cultures were taken one week after
COmPletion of oral therapy. In addition,
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Physical examination, urinalysis, electro-
Cardiograms’and antistreptolysin O estima-
tions were performed at stated times after
streptococcal infection as indicated below.
The following clinical criteria were selected
as evidence of streptococcal infection in this
Study: temPerature Of lOIOF. ora11y) Or
lO2OF. rectally; SOre throat; eXudate on ton-
sils; Or enlarged and tender cervical nodes.
METHOD
All patients satisfying the above criteria
had a double throat swab taken by the at-
tending medical student・ The swab was
streaked within four hours onto agar plates
containing 5 per cerit defibrinogenated sheep
blood. Plates were incubated at 37O C. for
twenty-four hours. When beta hemolysis was
noted, the cultures ‘Vere grOuPed and typed
by the Lancefield precipitin technic. If the
culture demonstrated Group A organisms and
the patient fu胤Ied the clinical criteria pre-
viously described, the index case and the fam-
ily contacts were accepted into the study.
Families were divided into two groups by al-
ternating days of primary case culture and
by designating certain fanilies to receive
chemoprophylaxis. Altemate families re-
ceived no prophylaxis.
When a culture was found to be positive)
the primary case was treated with penicillin
V potassium’群　400)000　units three times
daily for ten days. Patients with penici11in
sensitivity were treated with erythromycln
estolate,† 20 mg. per pound of body weight
per day in four divided doses’uP tO l gm.
daily for ten days.
After forty-eight hours, family contacts
were cultured. Secondary contacts with
positive Group A throat cultures were treated
with a similar course of therapy as prmary
cases, regardless of the presence or absence
of clinical symptomatology. Typing of §eC-
ondary cultures provided evidence of correla-
tion with the organism of the primary case.
Family contacts with negative throat cul-
tures of one group received penicillin or
erythromycm PrOPhylaxis in the daily dose
described above, but for three day§ Only. Neg-
ative contacts of the control group received
no prophylaxis.
義In the form of V-Cillin K, Eli Lilly and Com.
pany, Indianapolis, Indiana.
†In the form of IIo§One, Eli Lilly and Com-
pany, Indianapolis, Indiana・
FoLLOW_UP STUDY
The families were visited by the attend-
mg medical student and cIose attention was
directed to insure that the medication was
taken for the times prescribed. Home visits
were made every two to three days and in-
Cluded physical examination) Pill counting
and educating the patients towards the im-
POrtanCe Of following the prescribed regimen.
Duplicate throat swabs were taken from
all the family members at seventeen days
foIIowi g the primary case culture・ At this
time, the first mommg SPeClmen Of urine
WaS COllected from all patients previously
harboring Group A streptococci, and the
Sedimen s were examined by microscopy for
evidenc  f glomerulonephritis. After a pe-
riod of thirty days, these patients were also
glVen Physical examinations and electrocar-
diograms were perfomed for evidence of
rheumatic fever. A11 procedures were per-
formed by the same investigator.
RES ULTS
A total of 99 persons were observed during
the f ve-mOnth study period・ Of these) 20
Were Prl ary CaSeS Of Group A streptococ-
Cal pharyngitis. There were 79 family con-
tac s exposed to these prlmary CaSeS, 13 of
th se showed u tures positive for Group A
StrePtOCOCC  (Table l).
TABl.E l. Taかlla訪o?~ O/ Ca∫e∫.
The over-all secondary attack rate was 16.4
Per Cent and is somewhat higher than the
rate observed in a community study invoIv-
ing a higher socioeconomic level (Table 2).5
TABLE 2. Secol daγy A"ack Raie.
Secondary cases were subdivided into im-
mediate and delayed categories. An immedi-
ate secondary case was defined as a family
HASS : Sまγepiococcal Phaγyng妹　　　　　　　　　　　　　　　　　　　　　3
COntaCt With a positive culture obtained with-
in forty-eight hours of the diagnosis of the
Prmary illness. A delayed secondary casc
WaS One diagnosed any time after forty-eight
hours of the index case. Since al=amily
COntaCtS Were Cultured initially between
twenty-four and forty-eight hours after the
Prlmary CaSe, it became apparent that the
delayed secondary cuIture represented a more
accurate index of spread of the organism.
Of the 13 secondary cases’10 were immediate
and 3 were delayed (Table 3).
TABLE 3"　Amly∫i∫ Of Seco"daγy Ca∫e∫.
Secondary cases were further subdivided
into correlative and noncorrelative types. A
SeCOndary case was considered correlative
When an organism of the same type as the
Prlmary CaSe WaS isoIated. Of the 13　sec-
Ondary cases, Only 2 were correlative and
these were of the immediate category. There
Were nO delayed correlative secondary cases.
The correlative secondary attack rate was
2・5 per cent) aS COmPared with 16・4 per cent
for the total secondary attack rate.
Eighty-four per cent of the noncorrelative
Organisms were nontypable with obtainable
SerumS (Table 4).
TABLE 4. 4”aly∫i∫ OI Secondaγy Ca∫eらZc初Coγ-
γelaきio?2 0I Type∫.
Table 5 divides into two groups the fam-
ilies recelVmg PrOPhylactic antibiotics and
those recelVlng nOne. The 3 delayed sec-
Ondary cases in the control group had cul-
tures which) SerOlogically) Were nOntyPable.
They were from the same family of which
the primary case was also nontypable. These
3 secondary cases were symptomatic with
SeVere Pharyngitis. The family numbered
SeVen and lived under poor conditions in two
bedrooms. Among the group recelVmg PrO-
Phylaxis’there were no delayed secondary
CaSeS (Table 5),
TABLE 5. Fam砂ChemopγOphyla読.
EFFICACY OF TREATMENT
E飾cacy of treatment was assessed by the
number of patients with previously positive
Cultures rendered culturally negative at the
time of the seventeen-day fo11ow-uP. Of 33
Patients treated) Only one yielded a positive
th oat culture on fo11ow-uP. This constituted
a t atment succ s rate of 97 per cent, SOme-
What highe  than recorded by other workers.
There was no evidence of glomerulonephritis
Or rheumatic fever in any of the patients
Studied. Only 2O per cent of the antistrep-
tolysin O titers were more than 4OO Todd
units.
CoNCLUSION
As an index of spread of streptococcal in-
fection in families’the secondary attack rate
WaS de emined to be 16.4 per cent・ On fur-
ther analysis) this figure was reduced to 2.5
Per Cent for the correlative secondary attack
rate. When further divided into immediate
and delayed categories, it was∴Shown that
there were no delayed correIative secondary
CaSeS. Since it was assumed that this ex_
PreSSion was the most accurate index of the
SPread of infection, it must be concluded
that in this∴Study there was no signi丘cant
SPread of streptococcal infection within the
family. It should be noted’however’that
84 per cen  of the noncorreIative organisms
Were OntyPable with obtainable serums.
On might) therefore’POStulate that with
improved methods of typing, COrrelation
WOuld be higher and consequently spread
might be sh wn to be more significant・
Famil  chemoprophylaxis was not consid-
ered desir ble in e presence of streptococ-
Cal infection since there was no di鯖erence in
SPread of infection between the two groups
Of ati nts studied.
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The high success rate in treatment (97
per cent) was considered due to excellent
Patient co-OPeration’highly motivated stu-
dent participation in the study’and adequate
therapeutic doses of antibiotics. However’
additional studies would be desirable to
validate this point of view・
It has been shown in previous studies that
failure of treatment has been due most
COmmOnly to patients not following the pre-
SCribed treatment regimen.6
This was even more evident when oral
medication was prescribed, and it was shown
that parenteral antibiotic therapy gave bet-
ter results since patient co-OPeration was not
required.7 In spite of these facts) it is be-
1ieved that the high success rate shown above
glVeS gOOd evidence that, With adequate su-
PerVision) Patients may be stimulated to fol-
low through on oral treatment) Without re-
SOrting to the administration of intramuscular
antibiotics in the home, With all the at-
tendant hazards.
It is suggested that the one treatment fail-
ure may have been due to the action of peni-
Cillinase-PrOducing staphylococci present in
the pharynx, Throat culture in this case re-
Vealed a heavy growth of Siaphylococcu∫
aαγeぴ, Phage type 3A’insensitive to penicil-
1in. This patient’s throat culture revealed a
nontypable streptococcus on prlmary and fol-
low-uP Culture) SO it was not possible to state
Whether the organism was the sane in each
The suggested management of a fanily
exposed to streptocaccal infection would be
to culture all family members and treat only
those with positive cultures. The family
should be observed and further throat cul_
tures taken on the basis of clinical symp-
tomatoIogy which would indicate the neces-
Sity for treatment. Adequate doses of anti-
biotics should be maintained for ten days’
and follow-uP Cultures one week after the
COmPletion of therapy are considered desir-
able. Oral antibiotics are recommended’PrO-
Vided cIose supervision is maintained and
Patient co-OPeration is encouraged. Routine
SCreening for glomerulonephritis and rheu-
matic fever after streptococcal infections is
COnSidered desirable. It is suggested that
Physical examination and urinalysis wouId
su鯖ce.
SUMMARY
A pr liminary study in the home treatment
Of Gr しIP A beta-hemolytic streptococcal
Pharyngitis was carried out over a period of
nve months. Twenty families were fo11owed
CIosely to investigate the extent of spread of
the organism within the family. There was
minimal signific nt spread as detemined by
COrrelating the antigenic types from cultures
Of secondary cases with those of the primary
CaSeS. Nontypability was considered a maJOr
factor in the inabi ity to evaluate signi丘cant
SPread of the organism. Prophylactic antibi-
Otic therapy for family members was not ad-
VOCated on the basis of these findings. Rec-
Ommendations were suggested as to the
managem nt of  family exposed to strepto-
coccal infection.
I am indebted to Dr. Joseph M. Miller for his
advice and encoura?ement, tO Drs. Henry J. Bakst,
Alice T. Ma ston, Ge ald H, Whipple and Pauline
G. Stitt for their help, tO the Class of 1962　of
Boston University SchooI of Medicine for their
intere§t and co-OPeration, and to Eli Lilly and
C mpany for their generous donation of supplies
Of antibiotics used in this study.
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MALARIA
R印ort of a Case
DbNALD M.
M讐業pr蕊晋。雲霊も器楽
PrOblem when encountered in endemic areas.
However) in the academic teaching centers
of Boston and other North American cities
Where unusual diseases such as polymyositis
Or SyStemic lupus erythematosus are more
COmmOn than malaria, PrOmPt diagnosis can
be a problem.
S.H.’a tWenty-four-year-Old married Egyp-
tian exchange student, WaS referred to the
Massachusetts Memorial Hospitals because
Of recurring chills and fever of five days,
duration. Early in June, 1961, the patient
experienced a bout of hematuria which was
diagnosed as bilharzia ($chi∫io∫Oma hema-
iobic‘m)・ He was given a course of tartar
emetic. Upon leaving Cairo on July 6, 1961,
he felt entirely well. He stopped ovemight in
Copenhagen, Denmark, and flew on to New
York City, landing on July 7, 1961. He then
Came Straight to Boston. On August 7’1961,
thirty days after arrival,丘ve days prlOr tO ad-
mission) he developed general malaise, head-
ache) myalgias’including ocular myalgias,
backache) mild nausea and an oral tempera-
ture of lOO.2O F. Four days prior to ad-
mission the symptoms and low-grade fever
PerSisted・ An enema was given for constipa-
tion. On the third day prior to admission he
feIt much better and was afebrile・ Two days
Prior to admission he had a severe exacerba-
tion of his original symptoms complicated by
VOmiting・ He was seen by a prlVate Physician
Who administered aspirin’COdeine and pro-
Chlorperazine. He noted a chill early in the
aftemoon) Which was followed by profuse
SWeating and a temperature of lO3.80 F. On
the day pr10r tO admission the patient felt
moderately weak) but was otherwise asympto-
matic and afebrile. On awakening at 5 a.m.
On the day of admission he felt we11. His
temperature was 99.8O F. Shortly after lO
a.m・ he began to feel ill and noted a chill.
His temperature was lOO.3O F. By l p.m. the
i'Assistant resident’Department of Medicine,
Boston University Medical Center.
SMALL, M.D.埼
Patient,s oral temperature was lO4O F. and
he feIt extremely iIl・ Upon reaching the hos-
Pital at l :20 p.m. his rectal temperature wa§
105・80F・ (Fig. 1).
HOSPITAL DAYS
Figure l. - Rectal Temperature Variation While
in Ho§Pital.
The past history was signi丘cant in that the
Patient had had a bout of bilharzia mani_
fested by hematuria at the age of fifteen
Which was reated with 12 injections of
Fu din. Abou  one month prior to leaving
Egypt (June, 1961) he again had hematuria
d ag osed as bilh rzia and was glVen a COurSe
Of tartar emetic. He discontinued the drug
just before flying to the United States. In
1954 he had an illness characterized by per-
Sistent high fever and diagnosed as typhoid.
He was reated and recovered completely in
two weeks. He denied ever having had a
similar il ness. He had taken no chronic
medications. The family history and the re-
Vi w of systems were not enlightening. The
Patient lived in the Nile valley outside of
Cairo) an area endemic for malaria and hy-
Perendemic for S. hemaきobium.†
Physical examination revealed a rectal
temperature of lO5.80 F., the pulse 94 and
regular and the blood pressure 124/62. The
Patient was a well-developed, Well-nOurished,
†Craig, C. F., and Fau§t, E. C. Cl毒cal Paγa_
∫i青ology・ Sixth edition. 1078　pp. PhiladeIphia:
L a, 1957. P. 537.
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moderately pale, PrOfusely sweating) febrile
young male appearlng aCutely ill. The skin
was hot and wet; nO raSh, rOSe SPOtS, Pete-
chiae or jaundice were noted. One small
nontender lymph node was present in the
left axilla. Examination of the head, eyeS,
ears’nOSe and throat revealed large tonsils
With a few petechiae on the soft palate. No
scleral icterus was present. The neck was
supple. Chest expansion was excellent and
the lungs were clear. Examination of the
heart was normal. No murmurs were pres-
ent. The abdomen was soft and a丘rm spleen
tip was palpable in the left upper quadrant.
The rest of the examination was unremark-
able.
Laboratory data revealed that the packed-
cell volume was 36 per cent and the white-
cell count 7,900, With 17 mature neutrophils,
38 band foms, 1 eosinophil, 10 1ymphocytes,
32 atypica=ymphocytes and 2 monocytes.
No malarial parasites or nucleated red blood
cells were identified on initial examination of
original smears. Urinalysis showed a specific
gravity of l.012) PH 5.5) Protein trace) and
3十　Sugar (5 per cent intravenous glucose
running). Urinary sediment was negative ex-
cept for 2 to 7 red blood ce11s per high-POWer
field. BIood chemistries showed fasting blood
sugar 90 mg. per lOO ml・, blood urea nitro-
gen 17 mg. per lOO ml., Chloride lOl milli-
equlV. Per liter, Carbon dioxide 26 milliequiv.
per liter’amylase 41 mg. per lOO ml.’bili-
rubin 2.2 mg. per lOO ml・ COnjugated, 4・O
mg. per lOO ml.) tOtal. The febrile agglutinin
and heterophil were negative・ Cultures of
urine, StOOl, throat and blood (total of 7)
grew no pathogens. Films of the chest and
abdomen were unremarkable.
The patient was admitted on a Saturday
aftemoon and was noted to be quite sick with
a high fever. Initial physical exanination
and laboratory tests failed to establish the
diagnosis. He was treated with intravenous
fluids, alcohoI sponglng and aspirin. In four
hours his rectal temperature had dropped to
lO3O F. and eight hours later his temperature
was nomal. Except for moderate malaise
the patient felt well. The next day the pa-
tient felt we11 but the temperature rose to
IOl.60 F. He sweated profusely and appeared
slightly jaundiced. Blood smears revealed no
parasit s. The white-Cell count remained
nomal although  moderate shift to the left
PerSisted・ On the third hospital day the pa-
tient awakened feeling we11・ At lO:45 a.m.
h  began o have a severe shaking chi11・
BIood films were drawn and many malarial
ParaSites were identified. Morphology and
the presence of Sch珊ner’s granules strongly
suggested Pla∫mOdiαm諒ua〆infestation (Fig・
2). Th  patient was promptly started on
chlor quine, 1.O gm・ immediately and O.5
gm・ in six hours followed by O.5 gm. daily
for three days" By 12 noon the patient’s tem-
perature w s lO6.4O F. and despite liberal
aspirin t e temperature remained above
lO5O F. for four hours. The fever then
quickly lysed and the patient remained near-
1y afebrile for the rest of the hospitalization・
Primaquine) 15 mg. dailyクWaS added to chlo-
roquine therapy. After the fourth hospital
day the bloo  remained free of parasites. It
should b noted that re-eXamination of the
blood創ms drawn n admission revealed a
few parasi es which had been overlooked by
the house staff.
This represents a classical case of benign
and Mature Trophozoite (left) and Sch紺ner’s Granules in an Early Ring Form (right).
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tertian malaria which was overlooked by the
hoしISe Sta任for the first forty hours of hospi-
talization. Although maIaria had been con-
Sidered in the original differential diagnosis
the long incubation period (greater than thir-
ty-One days) mitigated against the diagnosis.
The remote possibility of a bite by an in-
fected Anopheles mosquito in Boston was dis-
missed. It is quite possible that the course of
tartar emetic which the patient took until
leaving Cairo may have suppressed the para-
Site and lengthened the incubation period,
In summary, malaria, One the world’s most
COmmOn diseases, does occur rarely in North
Ame ican cities and should be seriously
though  of in the differential diagnosis of
cute febrile diseases.
I m ind bted to Dr. Charles P. Emerson, De-
Partment Of Hematology, Massachusetts Memorial
Hospitals, and Dr. Matthew A. Derow, Department
Of Microbiology, Boston University School of Medi-
Cine, for their assistance in the identification of
the organism and m nagement of the case.
THYROTOXIC MYOPATHY
HYTHO V. HASEOTES掛
B葦荘e豊等詰蕊謹詳
attention to muscular weakness as an im-
POrtant SymPtOm in thyrotoxicosis. In 1895
Bathhurstl described a patient who had ex-
OPhthalmic goiter and severe muscle wasting.
Apparently this is the first instance in which
Sharp attention was focused on the possible
existence of a relationship between muscle
function and the thyroid gland・ This case’
however) along with those described by
Miesowicz in 1904 and Sattler in 1909, lacks
COmPleteness without basal metabolic rate
determinations and thyroidectomies and,
therefore) CannOt be designated as well-doc-
umented thyrotoxic myopathy. In 1908, Ren-
nie2 reported details concemmg a man tWen-
ty-SeVen yearS Of age who suffered from
exophthalmos) eXtemal ophthalmoplegia,
rapid exhaustion of the jaw muscles, Weak
trunk muscles) and easy exhaustion of the
deep reflexes. Rennie believed that two dis-
eases existed simultaneously in the same pa-
tient; these were probably exophthalmic
goiter and myasthenia gravis. Two addi-
tional early reports which lack evidence for
inclusion in the group called thyrotoxic my-
OPathy are those of Sterling (1930) and
Bemal (1939).
In the past twenty-four years the tem
=thyrotoxic myopathy,, or買chronic thyrotoxic
myopathy’’ has gradually entered medical
literature. There has been some confusion
COnCeming the diagnosis and frequency of
occurrence of this disorder and indeed some
廿Fourth-year Student, Boston University SchooI
of Medicine.
difference of opinion regarding the recognl-
tion of thyrotoxic myopathy as a specific dis-
ease ntity. The lack of consideration of
this disorder in the differential diagnosis of
C SeS PreSenting with symptoms of muscle
W akne s, atrOPhy, and tremor but without
Obvious manifestations of hyperthyroidism
has led to the mistaken diagnosis of this
COndition as myasthenia gravIS’amyOtrOPhic
lateral sclerosis) PrOgreSSive muscular atrophy,
muscular dystrophy’myOSitis’ and familial
Periodic paralysis. In view of the hopeless
PrOgnOSis presently assigned to most of these
muscle disorders which can be mimicke〔l
Clinically by thyrotoxic disease of muscle, it
is important to distinguish the latter disease
Since the prognosis fo1lowing thyroidectomy
Or antithyroid treatment has proved excellent
in the majority of cases reported.
CLINICAL MANIFESTATIONS
In thyrotoxic myopathy’tremOr’muSCle
WaSting) and weakness are of clinical impor-
tance.3・4
The myasthenia is constantly present and
is not benefited by rest・ Some patients will
be tired early in the moming・ The tremor
is usually丘ne and may become coarse or
more prominent when anxiety or muscular
effort is added. Tremor of the outstretched
hands is prominent and generaI muscular
WaSting with fasciculation is most marked in
the shoulder and pelvic girdles and less so
Peripherally i  the small muscles of the hands
and feet・5 The degree of weakness and fati-
gability may be greatly out of proportion to
the amount of muscular wasting, Whereas in
ProgreSSive muscular atrophy they tend to
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Parallel each other. Muscular fasciculation
is often very active and is apt to invoIve large
sheets of muscles and be more flash_like than
the fasciculation of progressive muscular
atrophy. Severe muscular cramps are apt to
OCCur during the night or on first using the
limbs in the moming. This tendency) also
Seen in some cases of progressive muscular
atrophy’WearS O任after a short period of
muscular activity.5 In many cases the fascic-
ulation is very slight or absent and the pic-
ture then may resemble muscular dystrophy.
Denervated skeletal muscle has been shown
to be increasingly sensitive after a period of
about丘ve davs to the chemical transmitter
acetylcholine and Denny-Brown and Pemy-
backer have suggested this explanation for
fasciculation in amyotrophic lateral sclerosis.
No degeneration of motor neurons occurs in
thyrotoxic myopathy’however’ and recov-
ery lS COmPlete following thyroidectomy. Fas-
Ciculation has, therefore, been ascribed to
One Of the following causes: increased sensi-
tivity of end-Plates or fibers due to metabolic
Changes resulting from hyperthyroidism; in-
CreaSe Of acetylcholine due to (a) increased
COnCentration of acetylcholine at end-Plates ;
(b) decreased concentration of acetylcho-
1inesterase. 5・6
Weakness of the Iegs is especially marked
and most patients complain of d脆culty in
CIimbing stairs and inability to take two steps
at a time (Plummer’s test), Squatting and
rising from a chair. One author records that
“on attempting to squat he does well until
the buttocks are about 18 inches from the
heels and then he goes down rapidly and on
attempting to sit down sIowly he drops into
the chair and camot arise sIowly鵜he must
hunch forward to get up without using his
upper extremities.”7　Lahey (1926) has
Shown that if a patient with thyrotoxic my-
OPathy, Seated in a chair, is asked to hold
One leg out straight and in a horizontal po-
Sition) he can do so for from twenty-five to
thirty seconds only, Whereas most nomals
Can do this for more than sixty seconds.8
HISTOPATHOLOGICAL FINDINGS
Most of the observations in the literature
emphasize that as a rule) the histopathoIogi-
Cal changes in striated muscles of the hyper-
thyroid individual are slight and nonspecific.
In 1898) Askanazy9 reported the post-mOrtem
examination of the muscles of 4 patients with
hyper hyroidism. H  observed severe muscle
at ophy with fatty degeneration and in餌ra-
tion; the atrophy was associated with pro-
1iferation of muscle nuclei・ Laquer’10 in
1901’described the presence of small round-
Cell in創tration in the muscles of a patient
With myasthenia gravis. In 1905, Buzzardll
StreSSed the importance of this observation
and called them負lymphorrhages." In 1911,
Dudg on examined a fatal case of exophthal-
ic goiter and noted extensive lymphocytic
in創tration of the muscIe tissue. During 1924,
Dudgeon nd Urquhart reviewed　8 more
CaSeS; in 7’Well marked ∬lymphorrhages,,
Were found. They stated that召the pathoIog-
ical findings in the muscles in myasthenia
gravis referred to in the literature are exactly
the same as our丘ndings in exophthalmic
goiter.,,12 In 1937) Eppinger13 reported his
findings of muscle degeneration associated
With pericap llary edema and thickening of
the capillaries. Liechti14 called attention to
the nonspecificity of the changes in the mus-
Cl  fibers and noted lymphorrhages in only
3 0f his 13 cas s. This was difI‘erent from
the observations of Dudgeon and Urquhart.12
It is noted by Rundle3 that lymphorrhages
are seen more in the extraocular muscles and
are uncommon in the skeletal muscle. Lev_
itt15 considered that白the presence of early
lymphorrhages) late lymphoid hyperplasia’
and final fibrosis in the muscles of both
m lignant exophthalmos) myaSthenia gravIS’
and lymphoid goiter) WOuld suggest a positive
correlation.,,
In 1953, Asboe-Hansen et al.16 described
the presence in the sarcolemma of accumu-
lations of a metachromatic substance. This
WaS nOt COrrOborated by Hed, Kirstein, and
Lundmark.17　The latter stressed the fact
that the changes were not severe and that
in most of their lO cases) nO definite pathoIog-
ical丘ndings were present other than a vary-
ing degree of atrophy of muscle fibers. They
did not observe the presence of fatty in創tra-
tion and in only 2 cases∴SeVere alterations
with muscle necrosis were found. Some au_
thors’ owever) COnSider the fatty degenera-
tion of he muscles a prominent finding and’
When present in the quadriceps’might ac-
COunt for the inab lity of the patients to lift
the foot.18
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Not only the “lymphorrhages’’but also the
Other changes which appear to be mOSt COn-
Stant in the muscles of the hyperthyroid pa-
tient with muscular alterations (atrophy of
the muscle fibers, fatty replacement and al-
terations in the staining reactions) have been
described in the muscle of patients with my-
asthenia gravis.19-21
PATHOLOGICAL PHYSIOLOGY
The endocrine glands have a definite in-
fluence on the e鯖ciency of muscular work.
There is impairment of the ability to sustain
WOrk output in certain animals during either
SeVere hyperthyroidism or hypothyroidism.22
The exact mechanism by which an excess
Of thyroid homone causes muscle weakness
is not known. The influence of thyroid dys-
function has been evaluated clinically and
COntradictory conclusions derived. Part of
the di鯖culty is a consequence of the prob-
lems invoIved in reaching a proper diagnosIS ;
Whether the patient had a true myasthenia
gravis associated with hyperthyroidism or
Whether there were signs of a chronic thyro-
toxic myopathy・
In severe thyrotoxicosis and even in milder
forms, there are more or less prominent signs
Of physical exhaustion. This is probably the
COnSequenCe Of derangement of the basic
Chemistry of muscular contraction. The total
muscular e億ciency in the hyperthyroid pa-
tient is severely impaired, and it has been
Shown that to do a glVen amOunt Of work,
these patients use approximately twice as
many calories as the normal.23　As e鯖ciency
becomes more impaired, the cost of work
becomes higher・
In bioIogical oxidation there is a coupling
Of oxidation and phosphorylation which pro-
Vides a means whereby the rate at which
foodstufrs may be bumed is regulated by
the requlrementS Of the cell for useful ener!ry.
The utilization of adenosine triphosphate to
drive the diverse energy-requlrlng PrOCeSSeS
Of the cell automatically increases the availa-
ble supply of adenosine diphosphate and in-
Organic phosphate, Which in tum become
available to react in the coupling mechanism
and permit respiration to proceed. It has
been demonstrated repeatedly that oxidation
Of the citric acid cycle intermediates by care-
fully prepared mitochondria is accompanied
by the formation of adenosine triphosphate
from adenosine diphosphate and inorganic
phosphat . The formation of adenosine tri-
P osphate under these conditions is unre-
lated to the initial step in which pyridine
nucleotides are reduced by the substrates.
Oxidation of DPNH by mitochondria occurs
with the formation of 3 moles of adenosine
triphosphate per mole of DPNH or per atom
Of oxygen consumed; this is conventionally
expressed as a P/O ratio of 3. If the γai∫On
d翌tγe Of carbohydrate and lipid metabolism
is the gene ation of energy-rich phosphate
COmPOunds to be empIoyed for endergonic
PurPOSeS, it is appa ent that this is achieved
not during the immediate oxidation of these
Various metabolite  elaborated from gluco§e
and lipid but during the subsequent oxida-
tion of the reduced coenzymes. Carbohydrate
nd lipid, the cellular fuels, SerVe, then, tO
maintain a supply of reduced coenzymeS.
However, little is known of the mechanism
Whereby electron transport is coupled with
the fomation of adenosine triphosphate.
When respiration and phosphoryIation are
uncoupled, the free energy of the respiratory
PrOCeSS is Iost to the cell and appears, WaSte-
fully, aS heat. Th e are a variety of reagents
Whichバuncouple,, oxidative phosphorylation.
e mo t frequently employed is 2,4-dinitro-
Ph ol, Which, in low concentration, abolishes
adenos ne triphosphate formation without af-
fecting resp ration. Other compounds which
xert similar actio  include pentachlorophe-
nol, methylene blue, aZide, arSenite and the
antibiotics, aureOmyCin and bacitracin, and
thyroxine.24
Many investigators have described the
ability of thyroxine and its analogues to un-
COuPle oxidative pho§Phorylation and pro-
duce c mpensatory increases in respiration
Of suspensions of mitochondria under special
COnditions.25,26　However, this in vitro un-
COuPling effect has been seen only with
COnCentrations of thyroxine which are at
least a thousand times greater than known
to be present in the tissues; furthemore,
inhibitory effects on oxidative phosphoryla-
tion of mitochondria isolated from the liver
follow tre tment of normal rats with
thyroxine are seen only after relatively enor-
mous doses which are far beyond the physio-
logical amounts required to produce mod-
e ate elevation of metabolic rates.27　Hoch28
SuggeStS that this may be due to deficient con一
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centration of the hormone actually reaching
the target sitc.
ln 1955, an Obscrvation was made that
put thc meChanism of action of thyroxine
on oxidative phosphorylation in a new per-
spective. It was found that oxidative phos-
phorylation accompanying electron transport
from l-hydroxybutyrate to oxygen could be
observed to take place in a submitochondrial
system, namely言n fragments prepared from
liver mitochondria by the action of digitonin・
In striking contrast to its action on intact
mitochondria, thyroxine was found to have
absolutely no uncoupling e鯖ect on phos-
phorylation as it occurred in the fragments’
although dinitrophenoI was fully active. Since
the fragments are both morphologically and
enzymatically simpler than the parent mito-
chondria’it appeared that the action of
thyroxine is not a direct one on some inter-
mediate or enzyme concemed in oxidative
phosphorylation but is rather an indirect
effect.29 A variety of explanations could be
evoked for this differential efI‘ect of thy-
roxine. For example’Perhaps an enzymic
transformation of thyroxine into the true un-
coupling agent takes place in intact mito-
chondria and cannot occur in the submito-
chondrial fragment for lack of the necessary
enzyme. A possible explanation was suggested
by Lehninger) Who found that thyroxine in
very low concentrations could cause rapid
swelling of isolated rat liver or kidney mito-
chondria in isotonic sucrose buffer at pH
7.4.29 Significantly it was found that DNP
did not produce swelling and in fact it
prevented swe11ing induced by thyroxine. It
was, therefore, POStulated that thyroxine is
not simply an analogue of DNP in its action
on uncoupling but has a separate mode of
action that is exerted primarily on some
property of the mitochondrial membrane
structure that leads to swelling and that can
also lead to uncoupling in an indirect man-
ner. It was found by Tapley that mitochon-
dria isolated from hyperthyroid rat livers
had a much higher rate of swelling than
did normal mitochondria; those from hypo-
thyroid rats were very resistant to spon-
taneous swelling. Sj6strand has found by
electron microscopy that the mitochondria
of hyperthyroid tissues are distinctly swollen
and show diffuse cristae.30 Lehninger noted
that the swelling activity of thyroxine and
its analogues follows, in general, their activity
in basal metabolic rate and -11CtamOrPhosis
tests.即
Although the effect of thyroxine on in-
hibition of oxidative phosphorylation or un-
COuPling of oxidative phosphorylation may
Serve aS an eXPlanation of some of the aspects
Of decreased e億cient power in thyrotoxicosis,
it does not account for the increase in §Ome
anabolic processes in thyrotoxicosis or under
the in租uence of administration of thyroid
homones, Or for the action of thyroxine in
the nomal thyroid state, Or for the bene-
ficial actions of thyroxine in hypothyroidism.
Hoch has proposed a hypothesis which
accounts for raised, nOrmal or low rates
of synthesis in response to thyroid hor-
mones.2S He postulates that low concentra-
tions of uncoupling agents) including thyroid
hormones, Change the relations of the res-
Piratory enzyme assemblies su鯖ciently to in-
crease the rate of oxidation without disturb-
ing (and even perhaps increasing) the trans-
fer of energy via the associated phosphoryl-
ative enzymes. Higher amounts of uncoupl-
mg agentS so alter the organization of the
mitochondrial apparatus that phosphoryla-
tive energy transfer is destroyed’but hyper-
OXidation continues. Hoch emphasizes that
this may be a dosage phenomenon: it really
doesn’t “uncouple” at low doses, Only at
high doses. If血e oxygen consumption is
more sensitive to Iow levels of thyroxine than
the coupling phenomenon) the so-Called un-
COuPler’at low doses, may be able to in-
CreaSe OXygen COnSumPtion, and hence, m-
CreaSe POWer, Without changing the P/O.28
Bronk,s recent studies with intact mito-
Chondri  and submitochondrial particles
showed no increase in oxidation rate associ-
ated with the lower P/O ratio of mitochon-
dria pretreated with thyroxine. He found no
evidence to indicate that the inhibitory ac-
tion of hyroxine on phosphorylation that
followe some change in mitochondria dur-
mg Preincubation was ever accompanied by
an incr ase in oxidative rate.31 This finding
indicated that thyroxine was not acting as
an uncoupling agent) but rather as an in-
hibitor of pho§PhoIγl tion.
It has been proposed that the impaired
muscl  fu ctio  in the patient with hyper-
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thyroidism may be related to a deficient
reconversion of the lactic acid produced dur-
mg muSCular contraction into glycogen.32・33
This idea) however, is not acceptable if we
COnSider that the appearance of muscular
fatigue does not result from the accumulation
Of lactic acid or complete utilization of glyco-
gen’but is primarily related to the disap-
PearanCe from the muscle of high-energy
Phosphorus compounds and particularly
adenosine triphosphate.34
Abnormal creatine and creatinine metabo_
lism have been attributed to disordered mus_
Cle metabolism・ In the hyperthyroid patient)
Creatinuria is found, aCCOmPanied by muscle
WaSting. Creatine is synthesized in the liver,
largely taken up by the muscles, and later
excreted in the urine as creatinine. If muscle
mass is decreased, eXCeSS Creatine is excreted
in the urine and the serum creatine exceeds
about O.6 mg. per lOO ml.; Creatinine ex-
Cretion is concomitantly decreased・35 Prob-
ably this excess creatine excretion is not in-
dicative of the site of the chemical disorder
Of muscle metabolism at the stage of phos-
Phocreatine excretion’ but results simply
from decreased muscle mass, because similar
Changes in creatine metabolism are found
in nomal old age as well as a variety of
other conditions with wasted muscles.36 It has
not been found that the change in creatine
metabolism accurately affects the severity of
the muscular lesion.17,37
$　　The recent丘ndings of Bertolini on the
efI‘ects of thyroidectomy and thyroxine on the
enzymatic activity of the heart muscle of the
7　rat are Of considerable importance. He came
to the conclusion that the variations in en_
Zymatic activity of the adenosine triphos-
Phate creatine kinase are strictly dependent
On the thyroid homone and that “increased
Or decreased thyroid incretion is constantly
associated with a decrease in activity of the
enzyme・,,38 Creatine phosphate is the source
Of high-energy Phosphate to accomplish the
PrOmPt reSynthesis of adenosine triphosphate.
In the resting state, the muscle contains four
to six times as much phosphocreatine as
adenosine triphosphate・ The immediate
SOurCe Of energy for muscular contractions is
PrObably adenosine triphosphate. The en-
Zyme that catalyzes the transfer of high-
energy phosphate from phosphocreatine to
adenosine diphosphate to produce adenosine
riphosphat  s the creatine kinase (Lohmann
re tion). Th refo e, if the creatine kinase
 the muscle is impaired in its enzymatic
activity, it is to b  expected that the sources
Of en rgy for m scular contraction will be
derang d. The findings of Bertolini of the
Variations in the enzymatic activity in the
heart f the experimental animal were first
Observed n vitro by A§konas’39 who reported
that DL- and L-thyroxine strongly inhibited
the activity of purified creatine phosphoki-
nase both in vitro and in vivo. The thyroid
homone  act primarily upon phosphocrea-
tine in vivo, ts concentration falling more
rapidly than that of creatine in muscle when
thyroxine is administered to rabbits.40 With
COntinued synthesis of creatine in the liver
and kid y) and inability of muscle to丘x
Or Synth s ze phosphocreatine, Creatinuria and
defects in the uptake of administered crea-
tine resul .41‾43　These defects were ascribed
to inadequate resynthesis of phosphocreatine
by Shorr et al.41,42 in 1933. With further
loss of oxidative power, failure of the syn-
thesis of creatine itself, Which requires adeno-
Sine triphosphate for the transfer of its
methyl group from methionine, Should de-
crease the creatinuria.28 This could account
for the fact that the degree of creatinuria
has not been found to parallel the severity
of the muscular lesion.
Alterations of transmission at the neuro_
muscular junction have been implicated in
hyperthyro dism.44 It has been suggested that
the muscular weakness in hyperthyroidism is
in part the manifestation of an excessive
amount of acetylcholine.44　However, there
is no convmClng eVidence that acetylcholine
Synthe s increase  in hyperthyroidism. Mas-
sari et al.45 show d that muscle cholinesterase
is decreased in athyroidism and increased in
the a imals rendered hyperthyroid with thy-
ro d hormone and suggested a possible re-
lationship betwe n their丘ndings and the
muscle weakness of hyperthyroidism. How-
ever, the absence of any e仔ect of drugs with
anti holinesterase activity on the weakness of
hyperthyroidism would tend to contradict any
Significant r lationship between the foregoing.
Muscle le§ions attributed to tocopherol de-
ficiency and pot tiated by thyroid homone
have been descr bed in experimental animals
and the possib lity that tocopherol deficiency
Or depletion in clinical hyperthyroidism is
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related to the muscle lesion was suggested
by Gimlettc in 1959.37 Postel46 found that
there was a cIose association between a re-
duced serum tocopherol level and severe
hyperthyroidism) but no correlation with the
degree of muscle invoIvement・ The results
Of tocopherol therapy in hyperthyroidi§m
have been indi任erent.37
Werk et al.47 recently reported a case of
the “stiff-man’’ syndrome associated with
hyperthyroidism. Treatment of the hyper-
thyroidism was followed by a decrease in the
marked generalized rigidity and spasms, but
moderate hypertonicity persisted. They sug-
gested that an associated hypothalamic dys-
function causing the muscular disturbances
was mediated separately from thyroid activ-
ity per se, although aggravated by the in-
creased thyroid function. The combination
of hyperthyroidism and Parkinsonism has
been ascribed similar correlation,48 but the
existence of any significant relationship be-
tween these two diseases is controversial.49
The clinical and experimental data culled
from the literature suggest that the relation-
Ship between thyroid function and muscle
weakness is far from a simple one. Many of
the observations are contradictory, Which is
to be expected in view of the present state
Of knowledge in the fields of muscle metabo-
1ism and thyroid physiology and chemistry.
REVIEW OF CASES OF THYROTOXIC MYOP_
ATHY REPORTED IN THE MEDICAL LITERA_
Thyrotoxic myopathy is the most frequent
muscular disturbance associated with hyper-
thyroidism.50 It seems likely that thyrotoxic
myopathy is fairly common) but because of
the di鯖erences of opinion regarding the di-
agnosis and even the existence of this dis-
Order, it is not commonly detected. In its
milder foms the muscular weakness is a
COmmOn SymPtOm, although it is perhaps
rarely noted in case history and examination,
being instead attributed to general asthenia・
In its more advanced fom, including pro-
nounced paresis and atrophy, it appears to
be less common.
Over the past 27 years over 90 well docu-
mented cases of thyrotoxic myopathy have
appeared in the literature.5,7・17・36,37,51-58 Of
91 cases reviewed by the author there were
45 males and 46 females. The average age
Of patients wi  hyrotoxic myopathy was
45.47 y ars, the age range being 18 to 70
years. In 56 0f the cases which reported the
du ation of symp oms the range was 7 weeks
to 15 years) the average duration of symp-
toms b ing 17,6 years. Sixty-SeVen Of the pa-
tients had tremor. Weight loss occurred in
all cases. Muscular weakness and wasting
Were nOted in all cases particularly in the
extremities) the shoulder girdle and the pel-
Vic girdl . The most severe atrophy occurred
in the shoulder girdle. Myopathic pattem in
the electromyogram was reported in 25 cases
and a nomal electromyogram was reported
in 4 case . The results following treatment
Of the hyperthyroidism are as follows: 85
recovered, 4 died and l not reported.
SUMMARY
A review and discussion of the literature
are presented regarding the muscular mani-
festations of hyp rthyroidism.
The clinical tr ad of importance in thyro-
toxic myopathy) namely tremor) muSCle wast-
mg and weakness, is discussed along with
other clinical manifestations.
The histopathological findings of =1ymphor-
rhages’,, atrophy) fatty degeneration and in-
filtration’and altered staining reactions in
thyrotoxic myopathy are nonspecific for this
disord er.
Various hypotheses on the etioIogy of thy-
rotoxic myopathy, data and a review of 91
CaSeS rePOrted in the medica=iterature are
PreSented.
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POSSIBLE IMPORTANCE OF ALTERED STEROID METABOLISM IN
ETIOLOGY OF WILSON,S DISEASE奉
P重elimina重y Report
SYDNEY WALKER
I嵩ご蕊二重認諾r嘉葦
tients with Wilson’s disease ( hepatolenticular
degeneration).1‾3 h spite of increased tissue
COPPer in the liver and brain, the scavenger
elements in these organs have never been
reported to show intracellular copper. (Nei-
ther is there any record of copper phago-
CytOSis in the spleen or lymph nodes.) The
microglia and von Kupffer cells’in fact’do
not seem to pick up any of the necrotic tissue
at the sites of the typica=esions. Given these
叩unds for this study were provided from the
United States Public Health Service, National In-
Stitutes of Health (Grant #4-990-000-873).
Accepted for publication January 27, 1963.
Patient ho§Pitalized at Boston Veterans Admin_
istration Hospital under the supervision of Dr, F.
Quadfasel, Chief of NeuroIogy.
†Third-year Student, Boston University School of
Medicine.
III, A.B., M.S.†
Observations, it would seem to me that there
may well be a gross lmPalment Of reticulo-
endothelial function in patients with hepa-
t Ienticular degeneration. This possibility has
not’tO my knowledge’been previously in-
VeStigated.
A second paradox which has not been
adequately ex lained is the marked function-
al renal disturbance in patients with hepa-
tol nticular degeneration - namely’amino-
aciduria) hypercalciuria) glucosurla, and
uricosuria.2,4-7　Perplexingly little or no
PathoIogy’g OSS Or microscopic’is found in
th  k dneys of these patients.7
The acknowledgment and consideration of
the above paradoxes, 1n aSSOCiation with cer-
tain known facts about steroid function, leads
One tO SuSPeCt that there is an abnormality
Of steroid metabolism in Wilson,s disease.
Nicol et al.8寸O have demonstrated the potent
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depressant effect of cortisone on phagocyto-
sis; this could be a clue to the reason for
the apparent paralysis of reticuloendothelial
activity. As for the abnomal renal tubular
function in hepatolenticular degeneration) it
is well known that certain steroids working
on ostensibly nomal kidneys are capable of
producing many of the urinary findings seen
in a patient with hepatolenticular degenera-
tion.11-14
The following experiment was conceived
to measure certain steroid activity of a pa-
tient with hepatolenticular degeneration and
to stimulate further investigation. A quan-
titative study of the urinary and plasma
steroids was made; and a qualitative chro-
matographic study訴of the urine was per-
formed.
METHODS
The experiment was designed to study
several aspects of steroid function in a pa-
tient with well documented Wilson’s dis-
ease. The baseline steroids were measured
in the blood and urine (17-hydroxysteroids,
1 7-ketosteroids, and ketogenic steroids in the
urine and plasma) ; the ability of the adrenal
gland to respond via steroid production was
tested by the standard suppression test)11
using dexamethasone; an attemPt WaS made
to demonstrate an abnormal steroid qualita-
tively by chromatographic methods.15
A thirty-Six-year-Old white male who) in
1946, WaS diagnosed as having hepatolenticu-
lar degeneration was studied. The patient had
been receiving 2 cc・ Of 2,3-dimercaptopro-
panol言ntramuscularly, tWice a week for the
past thirteen years. One week prior to the
period of study he was taken o任all medica-
tion.
During the six-day course of the suppres-
sion test, attemPtS Were made to keep the
patient calm and free from stress. He was
maintained on a standard hospital diet of
2500 calories per day. His vital signs were
recorded every four hours.
On the丘rst day) the baseline twenty-four-
hour urine was collected, and 30 cc. of blood
was taken from his antecubital vein in a
heparinized syringe. The blood was immedi-
ately centrifuged at 3500 rpm・ for thirty
i‘This∴Study was perfomed by S. Bursteinタ
Ph.D., Worcester Foundation for Experimental
BioIogy’Shrewsbury) Massa.chusetts・
m nutes and the plasma separated from the
red blood count. The former was then
f ozen at -5O C. and analyzed for plasma
ketogenic steroids.
On the second day) the twenty-four-hour
urine was collected, m王xed thoroughly and
frozen at -5O C. and a 200-ml. aliquot was
analyzed for 17-hydroxysteroids) 17-keto-
steroids, and ketogenic steroids. Another 200-
ml. aliquot was removed and analyzed for
ceruloplasmin) Calcium) glucose) uric acid)
and copper. The remaining 1800 cc. was
studi d ch omatographically for the presence
of an abnomal steroid of the glucocortico-
Steroid type.16
At 8 a.m. on the second day the ACTH
SuPPreSSion test was begun) uSlng Orally ad-
ministered dexanethasone, 0.5 mg. every six
hours for forty-eight hours.
On the third day’a SeCOnd refrigerated
twenty-four-ho r urine was begun. A lOO-
ml. aliqu t of this second twenty-four-hour
urine specimen was removed) frozen at -5O
C. and sent to the laboratory for analysis of
the above-mentioned steroids.
At 8 a.m. on the fourth day’the dose of
dexamethasone was increased to 2 mg. every
six hours for forty-eight hours.
On the fifth day’ a third) refrigerated
twenty-four-hour urine was begun. At 8 a.m・
30 cc. of blood was drawn into a heparinized
syrmge and centrifuged at 3500 rpm. for
t rty minutes. The plasma was removed
nd frozen at　-5O C.
On th sixth day a lOO-ml. aliquot of
urine was removed and frozen at -5O C. A
final venipuncture was performed with a 30-
cc. heparinized syringe; this was centrifuged
at 350O rpm. for thirty minutes and the
plasma separated and frozen at -50 C. These
specimens were analyzed for the same steroids
mentioned above.
CASE STUDY
R.K.’a thirty-Six-year-Old) White) Single
male’ developed d脆culty controlling the
movements of his right hand and am six-
teen years ago. This gradually spread to
include his left am and leg. His Ioss of con-
troI f movements was aggravated by excite-
ment’and the symptoms were accompanied
by a change in his temperament - 1abile
emotions, flares of temper and inappropriate
affect. At this time he was discharged from
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the Navy with the diagnosis of “Schizo-
Phrenia.” Since that time he has been chron-
ica11y hospitalized with Wilson’s disease and
has developed the fo1lowing signs and symp-
toms consistent with the diagnosis of hepa-
tolenticular degeneration: halting, Slurred
SPeeCh; a COarSe tremOr (17 per minute) of
his extremities; a broad-based gait) With
body bent forward and hands flapping at his
Sides; a blue-green ring in the comea near
the limbal junction bilaterally; mOderate
adiadochokinesis.
The family history was noncontributory.
He has 2 siblings without disease, and there
is no history of a similar a鯖iction in the
f脚ily.
Physical examination revealed a blood
PreSSure Of 132/72, the pulse 80, reSPirations
19 and a temperature of 98.60 F.
There was a large serp量gmOuS area Of pig-
mentation under the left axilla. Both feet
and ankles were diffusely, deeply pigmented.
The entire skin was mottled with very faint
Pigmented areas. Both thighs showed large,
depressed scars, 5 by 7 cm・, Which were at-
tributed to repeated injections of 2,3-dimer-
C aPtOP rOP anO l ・
Frontal bossing and tremor (17 per min-
ute) of the head was observed. There was
no ptosis or lid lag・ Three small (1 by l
mm・) pigmented spots were noted on the
lower lips, and there was telangectasia on the
media) SuPerior and posterior left alveolar
ridge. The patient,s tendency to drooI was
obvious.
The lungs were clear to auscultation and
PerCuSSion, Without rales or rhonchi. No
thrills or rubs were present. The point of
maximal impulse was in the fifth intercostal
SPaCe in the midclavicular line; the rhythm
was regular. A Grade 2 to 4 systolic mumur
WaS heard best at the apex. A large丘rm
mass, about 5 by 7 cm., WaS Palpated in the
left upper quadrant of the abdomen. Anal
SPhincter tone was decreased. Constant drib-
bling of urine was noted. Osseous defomities
On the distal phalanx of the third and fourth
digits of both hands were noted.
NeuroIogic examination revealed the pa-
tient to be right-handed, alert and well-Ori-
ented to time and place. His affect was
OCCaSionally out of proportion to the circum-
StanCeS) but not inappropriate to it.
Bilateral lateral nystagmus was demon-
Strated・ Speech was∴Slurred’ halting and
dysarthric. The fundi and visual fields were
nomal. The puPils were round and equally
reacted to light and accommodation, Brown-
ish-green Plgmentation was present bilaterally
at the comeal-1imbal junction. There was no
facial asymme ry) Or Weakness. The patient
drool continuously. He walked with a
Wide-b sed ai ) hands and ams flapping at
his sides. Both hands showed a slight tremor
at rest’Which became uncontrolledly exag-
gerated on contro11ed movement. There was
moderate adiad chokinesis. No visible mus_
Cular atrophy was noticed, but there ap-
Peared o be decr ased strength of grasp m
both hands especially on the right. All deep
tendon reflexes were depressed.
No appa nt sensory de丘cit was elicited
and meningeal signs were not demonstrated.
Bone marrows showed no hemosiderosis;
Pl te et precursors were decreased and the
myeloid erythroid ratio was decreased to l : 1.
Liver biopsy perfomed in November,
1946’Showed three lobes with focal §Camng
and focaI necrosis. Other liver-function tests
are rep rted in experimental results (Table
l).
TABLE l. LaboγatOγy Daまa befoγe a72d afteγ De在
ametha∫01きe釣IMγe∫∫ion読a Paiiem zu初W裾。壷
Di∫ea3e.
Th  phenoIsulfonphthalein was　85　per
Cent; Creatine clearance was 147 mg. per
twenty-four hours; albumin 840 mg. per 2400
CC・ Per tWenty-four hours. An intravenous
Pyelogram howed the left kidney to be 14〉4
??
?????????????
???????
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Cm・ The right kidney was I cm. sma11er. The
SPinal fluid was negative for colloidal gold・
FilmS Of the skull were grossly nomal with
hyperostosis in frontal bones; the pineal
gland was not calcified.
DISCUSSION
The seemingly heretical postulate that the
reticuloendothelial and renal response in
hepatolenticular degeneration is possibly in-
fluenced by abnormal steroid metabolism
might gain further credence if the following
facts were evaluated.
The recent reports of German and Beam17
regarding the beneficial effects of estrogen
in patients with hepatolenticular degenera-
tion have been an empirical evaluation, and
the precise mechanism has not been elu-
Cidated・ The studies of Nicol, Bilbey and
Ware16　on the reticuloendothelial system
have shown that various drugs influence the
Phagocytic activity of this system・ They re-
POrt that the estrogen analogue) diethylstiト
bestrol? is one of the most potent stimulants
Of phagocytic activity. Interestingly) Ludiny
et al.18 have reported that 2,3-dimercapto-
PrOPanOl, One Of the popular recent foms of
therapy in hepatolenticular degeneration and
One Which brings beneficial results in some
CaSeS, is also a very potent stimulant of the
reticuloendothelial system・ Could the effec-
tiveness of these drugs possibly be due to
such a stimulation of the reticuloendothelial
SyStem?
The fact that in Wilson,s disease there is
frequently glycosuria (without eIevation of
blood sugar) nO PanCreatic pathoIogy) and no
apparent kidney lesion) might be considered
in the light of the recent studies by Welsh
and Sims19 in which they postulate a pos-
Sible steroid affect on the kidney tubule,
resulting in reduced tubular reabsorption of
glucose from the glomerular filtrate and,
COnSequently, glycosuria without exceeding
the maximal tubular excretory capacity for
gluc○se・
The aminoaciduria, SO frequently associ-
ated with hepatolenticular degeneration,
might also be explained by the mechanism
Of glucocorticoid activity on the kidney
tubule.20
Hypercalciuria in the face of normal or
low serum calcium levels (as seen in hepato-
lenticular degeneration) has been reported
frequentIy in patients recelVlng COrtisol treat-
ments.11 In addition to the hypercalciuria
With increased glucocorticoids the same au-
thor rep。r S that osteoporosis may result from
the activity of these steroids. The frequent
reports of osseous involvement in patients
With hepatolenticular degeneration5 might be
re-eValuated’then) from the point of view of
steroid influence.
Just recently W esel20 has reported that
gluc corticostero ds show a strong propensity
to chelat c pper and fom an =ionic type,,
bound with the liberation of hydrogen. The
Phenomenon of chelation occurs in a ratio
Of l:1) 2:1 and 4:1. It is postulated by
Wiesel) that) i  the face of the rapid break-
down of the corticosteroids) there is a prov-
able c njugation with protein. He demon-
Strated that the chelation phenomenon was
OCCurring in local tissue area, that is, joint
fluid, and therefore excluded the aminoacid
implication in coupling with the copper.
RESULTS
In this preliminar  study of only l case,
no attempt can logically be made to try to
PrOVe Or disprove the proposed postulate of
a steroid abnomality. However? the reported
results are an attempt to bring attention to
the heretofore yet unexpIored parameter of
SterOid function and its implications in the
etioIogy of hepatolenticular degeneration.
The results of the quantitative analysis of
the urine and plasma steroid levels would
SuggeSt adrenal cortical deficiency but the
Patient had few signs or symptoms referable
to a decrease of steroids (Fig. 1). I would
POStulat that the deficiency might be in the
abnomal configuration of the particular
SterOid being pr duced; and that the meth-
Ods for meas rmg nOrmal cortisol and its
metabolites are inadequate to measure this
abnomal moiety・ This statement might be
further reinforced by the results of the
Chr matogr phy which showed a blue tetra-
ZOlium reducing zone of considerable in-
tensity (RF. = 0.2) in an area where nor-
mal urin  shows little or no discoIoration.
The low specific ty of the blue tetrazolium
reducing action does not pemit the precise
identification of this zone as a corticosteroid
Or SOme Other steroid, POSSibly a beta-6-hy-
droxycorticost roid type. Further investiga-
tion to elucidate the structure is under way.
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Figure l. ResuIts of Dexame血asone Suppression
Test on Stcroid Levels in a Patient with Wilson’s
Disease.
SUMMARY
Hepatolenticular degeneration has been
re-eValuated with regard to the potential im-
Plication of steroids in the disease process.
Various steroid parameters were studied in
a patient in whom the diagnosis of hepato-
lenticular degeneration was well established.
It was found that there were quantitatively
low levels of steroids in the face of signs and
symptoms that suggested increa§ed adrenal
activity. A qualitative) Semiquantitative
chromatographic study suggested a large
quantity of abnomal steroid on a portion of
the chronatograph where normally there is
little or no steroid.
Currently 6 other patients with hepato-
lenticular degeneration are being studied.
The results of these studies will be published
at a later date.
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MODERN CONCEPTS OF THE PLATELET IN HEALTH AND DISEASE導
J. WoRTH EsTES, A.B.†
CLINICAL PATHOLOGY
L苦言詣慧i悪霊露悪u‡
new methods of detemining the platelet
COunt are Published with alaming frequency,
the procedure of choice at this time is that of
Brecher et al.,96,97 which invoIves the enu-
meration of platelets in blood diluted with l
Per Cent ammOnium oxalate under the
Phase-COntraSt microscope. This method,
With an error of lO-12 per cent in my experi-
ence, aS Well as of others,97 shows the normal
Platelet count to be in the range of 150)000-
450,000 per cubic mi11imeter. The values so
Obtained are higher than those found with
the older indirect count, based on the number
Of red blood cells on the Wright-Stained
Smear; the discrepancy is due to the lack of
random distribution of the red blood cells on
the smear, Since most of these cells concen-
trate at the periphery rather than the center
Of the cover sliP.98　Gross estimation of血e
number of platelets on smear is not a useful
clinical tool.
Other quantitative and qualitative methods
Of study of platelets are discussed and out-
1ined in several recent volumes,97,99,1OO and
will not be detailed here. The in vitro meth_
Ods for studying platelet function in our labo-
ratory have recently been published,43 and
various modifications of the standard technics
are published, With most of the clinical papers
referTed to in this review.
One new method, Which, though it re-
qulreS SPeCial apparatus, SeemS tO be useful
in the assessment of the thrombocytopenias, is
the use of chromium51-labeled platelets in
measuring platelet life-SPan.23　This technic
Pemits a reclassification of the platelet de丘-
Ciencies on the basis of decreased production
or increased destruction, but is most useful in
describing the course of the diseases and
evaluating treatment.
i'Thesis written during the third year of medical
sch○○l.
†Fourth置year Student, Boston Univer§ity SchooI
of Medicine.
Diseases of platelets have been the subject
Of much discussion and many schemes of
Classification over the past ten years. We are
Only now sorting them all out and studying
their pathophysioIogy with a systematic ap-
PrOaCh. The outline to be followed here i§
Perhaps oversimp臆ed, but it should serve to
tie together some of the widely scattered frag-
ments of the literature. We will not be con-
Cemed with those diseases which, although
they show puapura as a maJOr manifestation,
are not diseases of the platelet itself) Or Which
do not affect血e platelet, SuCh as Henoch-
Sch6nlein purpura.
T HRO M BOCYTOPENIAS
The thrombacytopenias) Or quantitative
defects of platelets) may be considered most
COnVeniently as due either to production defi-
Cits or to increas d peripheral destruction, Or
o combinations of these two mechanisms.
The traditional separation into congenital
and acquired thrombocytopenias does not
emphasize the pa血ogenetic aspects to be of
use clinically. It i  of interest that in a recent
Study of 3,342 patients referred to one clinic
for valuation of their bleeding diatheses,
thrombocytopenia was　血e most frequent
COagulatio defect found.1OI
Thrombocytopenia due to a prmary pro-
duction de丘cit as been attributed to many
CauS S. These disea es are essentially amega-
karyocytic; the bone marrow is hypoplasticJ
and the platelets show a nomal life-SPan,23
unless previous isoimmunization has occurred
due to plat let or whole-blood transfusions.
There are many well-studied exogenous
c uses of bone-marrOW hypoplasia.102,103
Those which regularly depress血rombocyto-
POiesi , in su餓 ient dosage, include whole-
ody irradiation) the oncolytic drugs and
benzol. Th  latter two agents manifest血eir
effects largely as aplastic anemia and are
well desc ibed in various texts.
The effect of ;γγadia霧ion on platelets has
been well studied by several investigators
from different points of view. Purpura was
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found to be one of the best clinical indica_
tions of severity of exposure to the gamma
rays and neutrons of the 20-kiloton atom_
ic bombs dropped in Japan in 1945.1O4
The platelet count remained stable for three
to four days after the expIosions’and there-
after dropped rapidly to O in the second
Week, aS the circuIating platelets were de-
Pleted and not replaced by the bone mar-
row’the primary site of radiation damage.
The platelet count remained extremely low
for two to four weeks, during which time
Various hemorrhagic states appeared’Char-
acterized by increased capillary fragility)
CIotting time and bleeding time. Patients
exposed to about 400 roentgens or less began
to show improvement after two to　丘ve
Weeks; those exposed to higher doses failed
to respond to any therapy. The same clini-
Cal pattem was found in victims of two
maJOr POStWar nuClear accidents,105-107 al-
though bone-marrOW tranSfusion was effec-
tive in 4 patients who received estimated
doses of 60O to lOOO rem. At the same time,
increased levels of plasma factors V and VⅡ
Were found, due not to a direct effect of the
irradiation but secondary to the thrombo-
CytOPenia.
Irradiation of horse pIatelets in vitro has
been shown to depress certain enzyme sys-
tems’reSulting in decreased oxygen con-
SumPtion by the platelets.108　Disintegrated
Platelets are capable of correcting the coag-
ulation deficit but not the bleeding of irradi-
ated dogs; intact platelets are required to do
both.109　The total hemostatic defect pro-
duced by whole-body irradiation has been
POStulated to be caused by loss of the follow-
1ng Platelet functions;110　ability to form
hemostatic plugs) Va§OCOnStrictor substance’
interaction with AHF or other plasma fac-
tors’aCCeleration of prothrombin conversion’
and cIot retraction.
There are many agents which produce
amegakaryocytic thrombocytopenia alone or
as one manifestation of acquired aplastic
anemla) OCCaSionally: §eVeral antibiotics and
antimicrobials (chloramphenicol’ Sulfon?-
mides’StrePtOmyCin, the tetracyclines ; arSenト
Cals; Para-aminosalicylic acid) ; the hydan-
toins; SOme Of the antithyroid compounds;
Phenylbutazone; SeVeral minerals (arsenic,
gold, bismuth, Silver, merCury, lead) ; Certain
dyes and polishes (especially the∴aniline
dyes), insectic des, Organic soIvents and
Various ni rophenyl compounds.102 To track
down the exact cause of the patient,s dis-
ease, eXPert SearCh must be made for all
Of these agents, and others, in his history.
Endogenous caus s of platelet production
defic ts are more d珊cult to delineate.
Thrombocytopenic purpura is a frequent
first clinical manifestation of “congenital,,
apla∫tic鋤emi , Or may present by itself.
Def cts apparent at birth include Fanconi,J
J)mdγOme,111 in which thrombocytopenia is
as ociated with anemla) CutaneOuS Plgmen-
tation’microcephal  mental retardation’re-
tarded growth) teSticular hypoplasia’and
O h r congenital bnomalities. Other’PrOb-
ably related, COngenital amegakaryocytic
thrombocytopen as have been reported in
association with other varieties of anatomical
abnormal ties)112 especially absent radii. A
maturation disorder of megakaryocytes, aSSO-
Ciated with panmyelopathy and erythroblas-
tosis’has been reported on rare occasions’
Heggl祝　trymdγOme・113’114　The platelets
found in this disease show abortive dendritic
fo ms’1nCr aSed platelet volume’and defec-
tive structural metamorphosis. The throm-
bocytopenia of DiG2‘glielmo,∫ ∫yndγOmel15,116
is probably due to megakaryocytic deficiency.
A b zarre amegakaryocytic thrombocyto-
Penia occasiona11y occurs in hea上!γ0んe.4,117
At body temperatures over lO6O F., the
megakaryocytes show damage and disap-
PearanCe Of the nuclei before cytoplasmic dis-
SOlution into platelets occurs (though fibrin-
Olys s has been implicated as the direct
C uSe Of the thrombocytopenia more re-
Cently).118
Onyala l19・120 is a fom of thrombocyto-
Penic purpura) Characterized by distinctive
hemor hagic buIlae on the mucous mem-
b anes of the mouth and nose) OCCaSiona11y
ProgreSSlng tO eXSanguination due to hemor-
rhage of the urinary tract) gaStrOintestinal
tract a d uterus. The disease is found pre-
dominantly among the Bantus) and usually
runs a self-1imiting course, although it may
requlre rePeated blood transfusions. Though
megakaryocytes appear nomal on smear,
the disease appears to be one of platelet pro-
ducti n’Since there is no evidence of pIate-
let malfunction, Only of thrombocytopenia.
The specific cure for the disease is lemon
JulCe Or Vita調in C’but it is not yet known
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whether the basic lesion invoIves increased
renal ascorbic acid excretion, Or Perhaps an
unknown toxic factor. Onyalai may be re-
lated to the bleeding defect seen in the more
important vitamin C-de丘ciency disease)
∫C“γZ,y. A defect in Platelet Factor 3　has
been postulated in scurvy,121 but a more re-
Cent investigation122　presents evidence for
OCCaSional thrombocytopenia’and suggests
a possible comection between vitamin C
and the folic acid system in hematopoiesis,
with an imbalance of this relation in some
CaSeS Of scurvy. In this connection) it may
be noted that thrombocytopenia is infre-
quently associated with pemicious anemla’
and bone-marrOW aSPlratlOn reVeals few
megakaryocytes and rare thrombocytopoie-
Sis; the condition is reversed with liver-eX-
tract therapy.114,123《 The platelets that are
formed are increased in volume and show
decreased dendrite activity.114・124
One physioIogical cause of depressed
Platelet levels is memtγCJation.125 During the
fourteen days prior to the period of a nor-
mal woman) the platelet count sIowly de-
CreaSeS, and retums to normal rapidly after
the onset of menses. It is not known whether
this is due to changes in the hormones, the
bone marrow or the reticuloendothelial sys-
tem, but the change should be considered in
evaluating the platelet count in women of
the childbearing age group.
Thrombocytopenia due to predominant
Peripheral destruction includes the most
PuZZling of all platelet dyscrasias. There is
Still considerable controversy over some of
these diseases, and the literature is full of
COnflicting and inconsistent data’but some
general principles may be discemed, and
more advanced investigative technics wi11
eventually elucidate the various disease
mechanisms. The basis for the classification
Of these thrombocytopenias is a decrease in
Vivo life-SPan) With nomal megakaryocyte
activity.23 A production deficit may be asso-
Ciated, but it is probably secondary to bone-
marrow exhaustion following hyperplasia
induced by the increased peripheral destruc-
tion.
The major disease in this category lS SO-
Called ;diopathic !hγOmbocyiopenic 4uγpuγa・
We probably should abandon the丘rst word
Of the name, Since many definitely proven
etioIogies have been described, and in fact,
these various cau s may all precipitate the
same diseas .
Idiopathic thrombocytopenic purpura has
been differen iated into two clinical forms126:
an acute, Self-1imited thrombocytopenia
Which usually shows recovery within four
months of onset, and a chronic form exhibit-
1ng remissions and frequent exacerbations,
and showing decreased platelet levels (less
than 50 per cent of normal) even during
Periods of clinical remission・ In the differ-
entia  diagnosis f these two forms of idio-
Pathic hrombocytopenic purpura, the fol-
lowing po nts should be considered: the
Chronic form is more frequent in females
nd i older age groups, almost always pre-
SentS With a past history of untoward bleed-
1ng, rarely shows any accompanying lym-
Phocytosi or eosinophilia, mOre frequently
glVeS a POSitive family history of bruising or
thrombocytopenia, and about two-thirds of
the patients will respond to splenectomy, the
maj r form of therapy.
The cause of the platelet depression is
generally c nsidered to be immunoIogical in
Origin, but the nature of the antibody is in
dispu e, and, in fact, SeVeral antibodies may
be invoIved. Tullis127,128 has shown that the
Platele  antibodies of patients with idio-
Pathic thrombocytopenic purpura are true
antibod es, found in the gamma-globulin
fraction of idiopathic thrombocytopenic pur-
Pura Plasma; these antibodies are selectively
removed by abs rption with nomal human
Platelets, and their electrophoretic pattem
Shows them to li in the region of electrical
neutrality. A platelet agglutinin is found in
the bet 2-globulin fraction・129 In the pres-
ence of complement, Platelets that have
been agglutinated by antiserums undergo
lysis.130　Certain unrelated antigen-antibody
COmPlexe  may be adsorbed on platelets)
leading to their agglutination, and their lysis
in capill ries, Wi h release of serotonin and
histamine.130 The direct antiglobulin con-
SumPtion tes  gives similar results and per-
mits the demonstration of intracellular anti-
bodies.131,132 The Coombs test may also be
POSitive on plate量ets from patients with idio-
Pathic th ombocytopenic purpura129,133 and
may be positive with platelets from patients
With hemoly ic anemia but without throm-
bocytopenia.134 It is of interest to note, in
this connect on, that in patients with active
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red-blood-Cell hemolysis due to deficient
red-Cell glucose-6-Phosphate dehydrogenase’
their platelets also show a deficit of the
enzyme) but no thrombocytopenia.135
Plasma from patients with idiopathic
thrombocytopenic purpura reduces the plate-
let count of normal recipients.129,136,137 This
PrOPerty may remain after splenectomy) but
a nomal platelet count may also be main-
tained.136
The problem of false-POSitive platelet anti-
body tests occurs but infrequently. Those
found in patients with cirrhosis or conges-
tive spIenomegaly may actually be due to an
unmasking of nonantibody cytotoxicity by
the associated hypoalbuminemia.128　Other
false positives have been eliminated by the
removal of calcium and barium sulfate_
adsorbable serum factors.138 A very recent
Study丘nds no evidence for any platelet anti-
bodies in idiopathic thrombocytopenic pur-
Pura’139 and suggests that the platelets con-
tain a separate protein moiety which acts as
an antigenic stimulus・ An incomplete anti-
body has been shown in 50 per cent of plate-
let antibody seruns.140
The frequency of finding platelet anti-
bodies varies.127,131-133,138 They can be dem-
OnStrated in O to 4 per cent of normal sub-
jects, in 21 to 70 per cent of patients with
idiopathic thrombocytopenic purpura, in 2
to 23 per cent of cases with secondary throm-
bocytopenic purpuraJ in　66　per cent of
hypersplenic syndromes’and in 99 per cent
Of patients with systemic lupus erythemato-
The bone marrow of patients with idio-
Pathic thrombocytopenic purpura shows an
increased number of megakaryocytes’Pre-
dominantly young forms’ With decreased
granularity and platelet production; degen-
erative changes are seen in nucleus and cyto-
Plasm.123 PIatelets that are formed are fre-
quently large and bizarre, and have been
shown to bind less serotonin than nor_
mally.123’141 This evidence, and other data
discussed above) have suggested that idio-
Pathic thrombocytopenic purpura attacks
both the platelet and its parent cell.123’129
The role of the spleen in idiopathic throm-
bocytopenic purpura is still open to question’
though it probably does remove sensitized
Platelets) and perhaps produces a platelet
agglutinin.137　However, nO differences were
found in the platelet counts of splenic-artery
and splenic-Vein blood in idiopathic throm-
bocytopenic purpura or any other condition
investigated.142 It has been suggested that
the spleen regulates the maturation and re-
lease of plate e s) POSSibly under adrenal
COrtical influence) and explaining the e航cacy
Of ACTH in some cases of idiopathic throm-
bocytopenic purpura.143 Further evidence for
this role of the spleen is the丘nding that after
the injection of an aliquot of chromium51-
labeled platelets) they do not appear in the
Circulation for several hoursj indicating some
SOrt Of temporary sequestration.23　A few
CaSeS Of idiopathic thrombocytopenic pur-
Pura Subjected to splenectomy have shown
abnor al histiocyt s, filled with phospho-
1ipids (1arge y sphingomyelin).144,145　This
Phenomenon may be due to reticuloendo-
thelia  phagocytosis of platelets) but appar-
ently occurs so very rarely as to leave its
etioIogy in considerable doubt.
Neonatal thrombocytopenic puIPura137
may be found in the infants of mothers with
idiopathic thrombocytopenic purpura, aS a
result of the transplacental transfer of ma-
temal plat let agglutinins. More rarely’it
may be due to th  development of isoagglu-
tinins arising from fetal and matemal plate-
le incompatibility. Platelet antibody tests are
POSitive in about two-thirds of these mothers
and babies, but not always in both at the
same time.127
I iopa血ic血 ombocytopenic purpura has
been found o be血e foremnner of systemic
lupus ery血ematosus in growing nun-
bers.146・14了In one series of 51 splenectomized
Patients with idiopathic thrombocytopenic
PurPura at least 31・4 per cent developed
Other manifest tions of systemic lupus ery-
thematosus) and 15・7 per cent developed the
full-b own syndrome. These patients are pre-
POnderantly females. It is’therefore’Of the
utmost importance to consider virtually every
CaSe Of idiopathic thrombocytopenic purpura
as a potential case of systemic lupus ery-
thema osus) and t  maintain long-term fol-
1ow- P Studies on all patients with idiopathic
thrombocytopenic purpura. Though it has
been血 ught in the past that other rheuma-
toid di§eaSeS OCCaSionally exhibited thrombo-
CytOPenia’it is most likely that such cases
Were aCtu lly systemic lupus erythematosus
Which had not be n fully diagnosed・ The
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finding of platelet antibodies in 99 per cent
Of patients with system王c lupus erythema-
tosus132 may reinforce the autoantibody con-
CePt Of the basis for idiopathic thrombocyto-
Penic purpura. It should be mentioned here
that no platelet abnormality has been re-
POrted in patients with the discoid form of
lupus erythematosus.
Clinically, idiopathic thrombocytopenic
PurPura and most other forms of thrombo-
CytOPenia, aS Well as the qualitative defects
Of platelets, PreSent With petechiae and ecchy-
moses. Hematomas, Cerebral and gastrointes-
tinal hemorrhage, and hemarthroses, are
Other frequent丘ndings. Screening of the
Patient,s coagulation statu§ reVeals increased
bleeding time and capillary fragility) de-
CreaSed prothrombin consumption and cIot
retraction, and nomal cIotting time. Pro-
thrombin consumption and clot retraction
are directly proportional to the platelet
count.148 Recent work149 indicates that there
is little correlation between the platelet count
and the occurrence of purpura and hemor-
rhage. Instead, an Obscure link between
hemorrhagic phenomena and platelet throm-
boplastic factor, PrObably identical or similar
to Platelet Factor 3言s postulated, With pur-
Puric manifestations first occurring at platelet
thromboplastic factor levels of 25 to 55 per
Cent Of normal, and hemorrhage with less
than 25 per cent of normal platelet thrombo-
Plastic factor levels. This work requires more
extensive and carefully controlled con丘rma-
tion.
It may tum out to be of interest in the
Study of the pathogenesis of idiopathic throm-
bocytopenic purpura, and of apIastic anemia
With thrombocytopenia, that the leukocyte
alkaline phosphatase levels are moderately
low in these diseases.150 Supranoma=evels
Of this enzyme are obtained with ACTH
and steroid therapy.
Besides the “idiopathic’’form, there are
SeVeral foms of thrombocytopenic purpura
Of known etioIogy. Many dγug∫ induce im-
munological thrombocytopenia. The mecha-
nisms were first elucidated for Sedormid
(a11yl-isopropyl-aCetyl-Carbamide) ・151,152　Se-
domid combines with the platelets of “sensi-
tive’’patients to form an antigen complex;
this antigen and its antibody induce platelet
lysis in the presence of complement, A simi-
lar mechanism occurs with capillary endo-
thelium’SO that the resulting hemor血agic
tendency is due not to the thrombocytopenia
alone. Those patients who are sensitive to
Sedormid are also sensitive to other chemical_
ly related compounds.
S milar evidence has been presented for
thrombocytopenia due to quinidine hypersen-
Sitivity.153 In this case, the antibodies attach
to a platelet-quinidine complex, but com-
Plement is丘xed between two antibody mole-
Cules only when bo h antibodies have exactly
two (not one or three) quinidine molecules
att ched. This high degree of specificity
led to the uggestion that the adsorbed anti-
body so changed the platelet membrane as
to cause its moval from the circulation,
by phagocytosis or other splenic action;血is
mechan sm may be very like that which oc-
CurS  id opathic thrombocytopenic purpura.
Quinidine-indu ed thrombocytopenia154 is an
acute self-1imi ing di§eaSe With a good prog-
nos s if t e drug is stopped early in its
COurS . Th  diagnosis may be suggested by
the clinical appearance of hemorrhagic bul-
1ae on the oral mucosa.
Other drugs kn wn to produce what are
PrObably similar phenomena include certain
barbi urates, PyraZOIones, Sulfonamides and
arsenobenzoIs ; quinine ; Chlorprophenpyrida-
mine; digitoxin; PAS; and DDT. An even
l nger list as been incriminated at one
time or ano her.102 One last common drug
that is known to induce thrombocytopenia,
but rather due to some undetermined type
Of megakaryocyte suppression, is prednisone
in high dosage)155 used for maintenance of
Pat ents with idiopathic thrombocytopenic
PurPura. In prelimin ry clinical trials) intra-
VenOuS fat mulsions have produced several
thrombocytopenic conditions156,157 ; these are
thought to be due to overloading of the anti-
body mechanism of the reticuloendo血elial
system with fat, With subsequent activation
O  a pa ologic virus-Platelet antigen com-
plex.
A large group of ;nfecきioα∫ di∫ea∫e∫ has
be  implicat d in thrombocytopenic pur-
Pura・ Remission of the disease usually is
accompanied by a retum to nomal platelet
ev s, unles  hemorrhage intervenes. It may
be seen in tuberculosis,158 usually when there
is marrow invoIvement by the invading or-
ganism. A fulm nating purpura may occur
after scarlet fever? and mild thrombocyto-
24　THE BosTON MEDICAL QuARTERLY MARCH, 1963
Penia may occur with various streptococcal
infections.159 The anticoagulant effect of cer-
tain bacterial polysaccharides appears to be
enhanced in the presence of platelet-deficient
Plasma, aS in leukemia.160
V訪u∫e∫ have been responsible for some
instances of thrombocytopenic purpura and
PurPura fulminans. Among those viruses so
far incriminated are varicella,161・162 mumps,163
rubeola,164 and rubella.165,166 In uncompli-
Cated rubella, Platelet counts were found
to be low in most cases, and capillary fragil-
ity high, at the onset of the disease; these
findings reversed during convalescence・166 In
most cases’a hypersensitive mechanism has
been postulated. Influenza virus167 is thought
to be an antigenic link between platelets
and red blood cells言nducing their mixed
agglutination. Human bone-marrOW Pan-
hypoplasia has been produced experimentally
With Venezuelan equme enCePhalitis virus,
though the responsible mechanisms were not
discussed.168　Thrombocytopenia has been
noted in one disease of possible viral origin,
infectious mononucleosis, though it was
ascribed to hypersplenism・169,170 Several cases
Of a syndrome of hemolysis, thrombocyto-
Penia and renal disease have been re-
POrted171,172; an allergic response to a viral
infection, POSSibly of the lower intestinal
tract) WaS POStulated for some of these pa-
tients. It has been speculated165 that if an
immunological activity is responsible for these
CaSeS, With a virus-Platelet complex acting
as an antigen, may nOt many CaSeS Of “idio-
Pathic” thrombocytopenic purpura be due,
in reality, tO a Vims, eSPeCially following un-
recognized infections? Though the long
COurSe Of most thrombocytopenias argues
against this hypothesis, it certainly warrants
further careful, PrOSPeCtive investigation.
Thus, the nature of the platelet antibodies
is sti11 a mystery. It is not known whether
they are different for each precipitating case)
Or Whether they are homogeneous. The ap-
PearanCe Of thrombocytopenia with viral dis-
eases may not be due to any hypersensitive
mechanism, but may represent some extreme
fom of the disease. In this regard, it may
be remembered that in most of these cases,
at least in those in which a virus is recover-
able at all, the infecting agent cannot be
isolated by the time clinical manifestations
appear, PreSumably because by that time
the body’s defenses have produced enough
antibody to neutralize the invading virus,
nd yet this is th  time when the thrombo-
CytOPenia appears. Does the virus enter the
Platelet and/or megakaryocytes and produce
its effects intracellularly, and thus be outside
the range of antibody action?
Finally) there is a question as to the origin
Of the platelet antibody. Current thought is
that it is autoimmune in nature, but it cannot
be proven by any technics now available and
Only Hashimoto’s disease of the thyroid has
so far fitted all criteria for autoimmune dis_
ease. Th  evidence so far presented in a few
Well-Studied cases argues in favor of an iso-
nt body in response to a complex of platelet
and exogenous agen , Perhaps unidenti丘able,
SuCh as a virus or drug. Antibodies similar to
th s  of the blood groups camot be ruled
Out, and ne ther can cross-reaCtivity between
Platelets and the foreign material. We can
Only hope that there will be less precipitous
OPinionating and more recourse to sophisti-
Cated technology in the answering of these
questions. It should be remembered that cur-
rently available laboratory methods cannot
elucidate any responsible mechanisms.
Aldγich’∫ JyndγOme is a rare fatal disease
manifest d as th ombocytopenia’eCZema and
infection in infants"1了3,174 Platelet production
is nomal’aS is the immune response. The
basic condition seems to be a genetically
d termined liability to infection, With a §eC-
Ondary thrombocytopenia.
The r maining forms of thrombocytopenia
due to increased peripheral removal are more
mechanica  in their pathogenesis. One rare
entity is thromb cytopenia due to sequestra-
tion of the platel ts within a giant hemangl-
Oma in fants.175 The resulting purpura is
r versed wi h x_irradiation to the tumor.
ThγOmbotic !hγOmbocy青openic 4αγpuγa is
a bizarre syndrom  which includes hemolytic
anemia and euroIogical symptoms.176‾179
Pathological studies show endothelial prolif-
ration and platelet thrombi in teminal ar-
terioles and cap llaries. The disease is rapidly
ProgreSSive and fatal and is usually diagnosed
Only at autopsy. It appears to be the result of
a hypersensitive state of the red blood cells,
Pl telets and endothelium, though no platelet
ag lutinins or red-blood葛Cell hemolysins have
been demonstrated; a Shortened platelet life-
SPan has been shown. More recently) it has
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been suggested that thrombotic thrombocyto-
Penic purpura is pathogenetically similar to
eclanpsia, and that -the thrombi are com-
POSed not of platelets but of fibrin.180
The role of the platelets in Jhock has been
explored to some extent・ In experimental
hemorrhagic shock in the rabbit,181 three
Phases are noted: an initial hypercoagulable
Stage, With increased platelet counts and
thromboplastin generation and a rapid de-
CreaSe in fibrinogen; this is followed by ab-
nomally low platelet levels, fibrinogen con-
Centration and plasma coagulation factors;
the final stage is a retum to noma=evels
Of these parameters if the bleeding is stopped.
Widespread intravascular clotting was seen
histoIogically, POSSibly around foci of platelet
microthrombi. Studies on anaphylactic and
PePtOne Shock182 in the rabbit reveal that
the degree of thrombocytopenia is a constant
indication of antigen sensitization and severity
Of shock. At the sane time, there is a correla-
tion between the disintegration of white
blood cells and platelets and the liberation
of histamine. The intracellular reaction be_
tween antigen and antibody apparently re-
Sults in the activation of a proteolytic en-
zyme, PrObably trypsin, Which releases hista-
mine bound to intracellular protein. The
disintegrated platelets appear to clump and)
with the added influence of histamine, Ob-
struct the small blood vessels. However, the
hemorrhage seen in thrombocytopenic shock
is not due to the fall in circulating platelets)
but to products of their disintegration. These
mechanisms may not operate in man) Whose
platelets contain less histamine than those
of rabbits, but they nevertheless provide a
model for future investigation.
Su(geγy and some of its special technics
have measurable effects on human platelet
levels. A lO per cent increase in platelet
COunt is found immediately postoperatively
in nontransfused nomothermic patients.183
The platelet count retums to preoperative
levels in about three days. Marked thrombo-
CytOPenia is usually seen in operations under
hypothemic conditions at 25O C. or below?
associated with increased cIotting time and
decreased prothrombin consumption.184 E在
tγaCOγpOγeal ciγCt‘lation technics destroy large
amounts of both donor and recipient plate-
lets.185-187 The abnormal bleeding observed
after some of these operations does not seem
to be due to the thrombocytopenia so much
as to the hypercoagulability and subsequent
intravascular clotting due to platelet disrup-
tion. As a result, Plasma coagulation factors
are depleted and increased fibrinolysis oc-
CurS, leading to a hemorrhagic diathesis.
Platelet Factor 4 d ficiency may be invoIved
as well.
Thrombo ytopenia and bleeding are fre-
quently induced by exchange tran§fusion or
the ma∫∫iz,e　きγan∫fu∫ion of banked blood
StOred for more than one day.188-190 This ef-
fect is enhanced in patients with pre-eXist-
1ng COagulation abnormalities, aS in liver
dis ase and hypersplenic syndromes, and is
largely due to the inability of stored blood
Platelets to circulate. It is also possible that
Platelets are consumed during storage by
Slowly p ogressive thromboplastic activity
Which is not completely prevented by stan-
dard anticoagulat ng technics. All patients
in whom massive transfusion is deemed prob-
able, eSPeCia11y those with hepatic damage,
Should have p eoperative studies of their
Platelet levels and prothrombin-COmPlex fac-
tors performed, and fresh blood should be
made available. Tγamfu∫ion γeaCiio榔have
also be n associated with thrombocyto-
Penia)191 secondary to intravascular cIotting
nd release of platelet thromboplastin.
THROMBOCYTOSES
Increased numb r  of platelets are also
associated with bleeding dyscrasias.
Hemoγγhagic thr mbocythemia192-194 is a
rare and unusual myeloproliferative disorder
Of th  platelets, in which the severity of the
bleeding mapifestations is roughly propor-
tional to the platelet count. The platelets
are prob bly functionally nomal) Since they
Will correct th  bleeding of a thrombocyto-
Penic recipient. The platelets of patients
a触cted with hemorrhagic thrombocythemia
have been found to bind less serotonin than
those of nomal subjects, but this may be
becaus  the umber of platelets in the body
exceeds the available serotonin stores. In
some patients’the spleen has been found to
be absent or atrophic, but it has been en-
1arged in others. The hemorrhagic episodes
have been ascribed to an anticoagulant effect
of th  excess platelets, inhibiting the throm-
bopla tin phase of coagulation'
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Polycγ沈emia z,eγal14,195‾197 is probably a
divergent fom of myeloproliferative disorder.
Platelets from polycythemic blood show a
shortened life-SPan When infused in thrombo-
cytopenic recipients) but any hemorrhagic
manifestations in the recipients remain im-
proved for several hours after the transfusion.
It is now thought that the bleeding tendency
seen in some polycythemic patients is most
likely due to a qualitative defect of platelets)
Platelet Factor　3　deficiency. Exaggerated
structural metamorphosis is also seen. Bone-
marrow depressants such as radioactive P32
and urethane seem to be of some value in
the controI of the disease’though periodic
Phlebotomy is the traditional regimen.
An interesting facet of the thrombocytotic
syndromes is the appearance of hyperka-
lemia’198 due to the release of potassium
from the excess number of platelets" There
is no increase in platelet potassium concen-
tration. As yet) nO Signs or symPtOmS Of
hyperkalemia have been reported in these
Patients・
Q廿ALITATrVE DEFECTS OF PLATELETS
These diseases have long been regarded as
a group of esoteric and unexplained condi-
tions, Whether prlmary Platelet dyscrasias
or secondary to other diseases・ In the last
few years the pathophysioIogy has been de-
temined for some of them, and important
inroads have been made in others.
ThγOmbocyきopaihy, a PurPuric condition
characterized by increased bleeding time)
normal clot retraction and platelet count,
and defective prothrombin consumption and
platelet thromboplastin generation test, is
thought to be due to an inability of the plate-
lets to release Platelet Factor 3 upon activa-
tion of the coagulation mechanism・114,199-2OI
There is no intrinsic deficit of Platelet Factor
3, Since incubation of the patient,s platelets
in distilled water, Or their subjection to
sonic oscillation, Pemits their nomal per-
fomance in the thromboplastin generation
test’but the platelets show an increased
osmotic resistance. Defective aggregation but
excess structural metamorphosis are seen’and
the chromomere, Which contains Platelet
Factor 3, is not released easily. There appears
to be no defect in capillary structure. Aniso-
cytosis of the platelets has been described)
and asc ibed to an abnormal cell-Wa11 1ipo-
protein. The disease produces a mild to
moderate hemorrh gic diathesisj and is
thought to be the result of non-SeX・1inked
simple dominant genetic transmission・ It has
also been reported in association with AHF
deficiency, aS thrombocytopathia hemophili-
ca.201
ThγOmbocyioa∫才henia is a disease charac-
terized by incr ased bleeding time) nOmal
platelet count and Platelet Factor　3) and
decrea ed clot retraction.199,2OI MorphoIog-
ically’the plat lets show defective pseudopod
fomati n and adhesiveness, With lack of
hyalomere s reading・ It is not known whether
the disease arises spontaneously) Or if it is
due to a simple recessive genetic factor.
In association with AHF or PTC deficiency,
thi  c ndition is known as thrombocytoas-
thenia hemophilica, but it is further dis-
tinguished fr m the more frequent disease
by nomal clot retraction.201
A c mbination of these two diseases has
been described as thrombocytoasthenia throm-
bocytopathia, manifested by increased bleed-
ing time’ decreased cIot retraction and
Platelet Factor 3 release’and normal platelet
count.201 Mo phoIogically’defective aggrega-
tion’ adh sion, PSeudopod fomation and
hy lomere sp eading of the platelets are
MacγOglobz‘linemia frequently presents with
a hemorrhagic diathesis. This has been shown
to be due to the physicochemical activity of
the abnomal gl bulin covering the platelet
and prev nting he release of Platelet Factor
3.202’203 There is no evidence for any anti-
platelet immunological activity of the ab-
normal globulin ; its inhibitory e鯖ect appears
to be directly proportional to its molecular
size. Dendrites are not fomed by the affected
platelets, PreSumably due to a restraining
apacity of their p otein covering. Screening
tests will usual y reveal increased bleeding
ime, nOrmal clot retraction, decreased pro-
hromb n and prothrombin consumption, and
low levels of fibri ogen; Circulating antico-
agulants may have to be ruled out・ There is
evidence that dextran may act in much the
same way m maSSive doses.2O4
The pathogenesis of bleeding in Je話emia
is not w ll understood.　Current evi-
dencel14’149,ZO5-2O8　fails to demonstrate any
con ist t defici ncies that can cause bleed-
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ing・ Thrombocytopenia and deficient plasma
Factor V levels are most frequently found,
but they do not correlate with thc hemor-
rhagic tendency. Platelet thromboplastic
function is frequently decreased) aS is serum
serotonin (i.e., either platelet serotonin or
platelet release of serotonin). Clinical bleed一
mg rarely occurs at platelet levels over 50)000
per cubic millimeter) but it may) and bleed-
ing does not always occur at even lower
platelet counts. Structural metamorphosis
may not occur’and platelets may be swollen
and without dendrites. Thus it seems that
血e overa11 functional hemostatic activity of
the platelet is invoIved in leukemic hemor-
rhage) and probably includes vascular fac-
tors as well.
In other malignancies) thrombocytopenia
is occasionally seen secondary to bone-mar-
row invasion by the tumor cell. However)
functional defects in the platelet may also
be detected on rare occasions.
Uγemia is occasionally accompanied by a
bleeding abnormality. The hemorrhagic tend-
ency has been ascribed and denied to many
mechanisms,64・209-215 and probably no one in-
dividual mechanism is responsible in all cases・
Roughly half of all bleeding uremic patients
exhibit mild to moderate thrombocytopenia.
Some of the rest show nomal platelet counts
but definite thrombocytopathies have been
demonstrated in them’including de丘ciencies
of Platelet Factors 3 and 4. Deficiencies in
some of the plasma coagulation factors have
been found in a few patients. Platelet sero-
tonin is frequently low. Capillary fragility is
occasiona11y observed. CIotting and bleeding
times may be proIonged) but cIot retraction
is usually normal・ No morphoIogic abnomali-
ties have been described in the platelets’and
thrombopoiesis appears to be nomal. Plate-
let phosphatides are normal. In these studies
no correlation between blood urea nitrogen
or nonprotein nitrogen and bleeding was
found, and urea was found not to be the
major factor. There was some degree of
correlation between bleeding and duration
of anuria in acute renal failure, but not in
long-Standing chronic disease. In the face of
this evidence’We Can Only accept a postu-
late of multiple qualitative and quantitative
defects of unknown origin at this time.
Liver disease is frequently accompanied by
platelet defects.91,209,216　Mild thrombocyto-
Penia has been reported, but a defect in
Platelet thromboplastic activity (Platelet
Factor 3リhas b en found most often, uSual-
1y associated with decreased plasma coagula-
tion factors. Platelet Factor 4 has also been
found decreased.
THERAPY OF PLATELET DISORDERS
The management of the diseases discussed
in the pr vious section of this review presents
SOme Of the most challenging problems in
mode  medicine. It must be emphasized at
the begiming that here is no standardized
regimen for any of these cases, but most re-
quire subtle manipulation of existing tech-
nics. In addition, We are gradua11y building
up an amamentarium of new agents that
Show promise for the near future.
Not all of th  platelet diseases are anena-
ble to treatment by their nature. The major
treatable diseases, Which numerically outrank
all the others, are the thronbocytopenias,
and these are the main topic of the remainder
Of this review. The primary qualitative de-
fects are largely untreatable, but are also
frequently mild and not life-threatening. In
SuCh patients) rePlacement and supportive
therapy are usually beneficial in hemorrhagic
Crises. Treatment of the underlying cause of
SeCOndary qualitative and quantitative defects
will usually corr ct the hemorrhagic tend-
enc es. The thrombocytoses show remission
following phlebotomy.
The generally acc pted critical platelet
level is 50,00O per cubic millimeter; bleeding
is more likely to occur at levels of less than
lO,000 per cubic millimeter) and does not
OCCur With more than lOO,OOO platelets per
cubic m llimeter in the absence of qualitative
Platelet or o her coaguIation factor defects
(though  few patients undergoing major
Surgery Will bleed with 150,000 platelets per
cubic millimeter, largely due to associated
Pl sma prote  defects).217　Clinica11y, We
should like to maintain levels of at least
bout lOO,000 platelets per cubic millimeter.
Bone-m γγOZ4, Jγan∫fu5ion has become the
treatment of choice for irradiation injury
syndromeslO6’218 in the absence of other dis-
ease, and isologous grafts appear to perfom
th e tire hematopoietic function for a month
Or so until the patient’s own marrow re-
covers. AutoIogous, homoIogous and isolo-
gous bone-marrOW tranSfusions have been used
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With varying success in producing temporary
remission of leukemia following whole-body
x-irradiation.219-222 The technic has also been
used successfully in aplastic anemia223 and
SeCOndary thrombocytopenia of unknown ori一
軍n.224
Whole-blood ,γa可cバion is useful in the
management of mild qualitative and quanti-
tative deficiencies of platelets. As noted earli-
er) it must be fresh in order to supply appro-
Priate amounts of platelets. Five per cent of
donor platelets are lost by collection alone
into acid-Citrate-dextrose solution in glass
bottles or plastic bags, followed by a 2 to 3
Per Cent loss daily during storage for twenty-
One days.225 No morphoIogical changes were
noted. However, despite thi§ SIow Ioss of the
Platelets themselves, the remaining platelets
Show a survival time inversely proportional
to the length of storage of the blood,226・227
as detemined by their ability to circulate
in the recipient’s bloodstream.
In an e任ort to study the platelet defects
Which develop during routine blood banking
StOrage Of whole blood anticoagulated with
acid-Citrate-dextrose and stored in plastic
bags, With the idea of salvaging the platelets
remaining after twenty-One days of storage
at 4O C., the author has measured the major
Platelet factors and some metabolic aspects
Of fresh and stored platelets.43 Platelet Fac-
tors l and 2 were severely diminished after
twenty-One days; Platelet Factors 3 and 4
were normal; CIot retraction decreased
gradually until its complete disappearance
in fourteen to twenty-One days; aerobic
and anaerobic metabolism by the platelets
was not significantly reduced at the end of
the storage period. These results) along with
those of others,228 indicate that from all
parameters that can be studied conveniently)
Platelets in blood stored for more than one
day should be effective in the controI of
hemostasis, Or at least some aspects of it.
Platelei ±γan∫fα5ion∫ have been the subject
Of much study in recent years. They are de-
Sirable largely in the hope of avoiding over-
transfusion with whole blood in patients
Whose major defect is primary or secondary
thrombocytopenia.229 Fresh platelets, COllected
in acid-Citrate-dextrose, SeParated by differ-
ential centrifugation from blood of com-
Patible blood groups, and resuspended in the
Parent Plasma, are given for many thrombo-
CytOPenic emergencies. However, this method
is cumbersome for most blood banks, and a
m t od of preservlng SeParated platelets
alone is in great demand. It must be remem-
bered that even fresh platelet transfusions are
not always useful) aS in idiopathic thrombo-
CytOPenic purpura, in which the infused
Platelets are destroyed soon after infusion.
In hese patients) Platelet transfusion is valu-
able immediately after splenectomy.23O Re-
fractoriness may develop to multiple platelet
transfusions’With decreased platelet survival
and perhaps deve opment of antiplatelet sub-
StanCeS in some cases.230,231 In one series, nO
Platelet antibodies could be demonstrated
after multipl  hemostatically effective fresh
Platelet transfusions.232
Platelet preparations are usually evaluated
by their ability to depress the appearance
O red blood cells in the lymph of the cannu-
lated th racic duc  of x-irradiated dogs,233
by measurement of their life-SPan,234,235 or by
Various in vitro technics for studying indi-
Vidual cl tting factors. Of those platelet
PrePar tions which have been studied, the
foll wing have showed some indication of
usefulness, but none has been used exten-
Sively or is likely to be in the near future:
COllect in pl stic bags and EDTA,234,236
frozen in parent plasma)237 and frozen in
EDTA and/or glycerol.235,238　Lyophilized
(freeze-dried) platelet material,239-241 and
Platele s preserved in gelatin at 4O C.)242
h ve shown most promise clinically. A
CePhalin complex has been reported to pro-
duc favorable changes in patients with idio-
Pathic thrombocytopenic purpura.243　Ex-
Change ransfusion may be of value in con-
genital thrombocytopenic purpura with
platelet antibodies, manifested in infants.244
The?nanagem i o声diopaihic JhγOmbo-
Cyiopemc 4uγpuγa is only occasionally d臆-
Cult. Each patient requires individually tai-
lored therapy’but if properly thought out
and ex cuted pemanent remissions are fre-
quently obtained.
Platelet transfusions, including whole-blood
transfusions, may be useful in acute hemor-
hagic c i es of idiopathic thrombocytopenic
PurPura) and in pr paration for surgery) but
they r  wasted in long-term treatment, for
the reasons discussed above. They are most
Valuabl  in the amegakaryocytic thrombo-
CytOPeni s.245
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Splenectomy alone produces complete re-
mission in 60 to 90 per cent of cases of
idiopathic thrombocytopenic purpura in most
large series’147・246-248 and is more likely to
be e億cacious if the patient has previously
Showed some response to steroids)248 though
in these same series steroid therapy alone
PrOduced few complete remissions. The
SterOids most likely to be clinically use-
ful are cortisone and prednisone, along with
ACTH.249-252 Care must be taken with pred-
nisone) Since in high doses it shows a throm-
bocytopenic effect.155 The clinical e鱒ects of
these drugs are usually due’however’ tO
improvement of vascular fragility’and not to
any direct effect on platelets. Steroids are
definitely indicated in preparation for sple-
nectomy) and may be useful in moderate
nonsurgical cases. It should be remembered
that children and adolescents are likely to
undergo spontaneous remission’and should
be followed carefully for six to twelve months
before drastic treatment is instituted.246
Apla∫iic memia has recently been
treated successfu=y with testosterone in some
CaSeS.253’254　Even without complete remis-
Sions) the homone permits the maintenance
Of satisfactory platelet levels. Previously’the
Only useful therapy has been repeated blood
transfusions.
SUMMARY
The recent literature of the normal and
abnomal structure and function of the plate-
let has been reviewed) With emphasis on the
Pathophysiology of the platelet disorders.
There are still many questions to be an-
SWered・ One of the most pressing is the
nature of the antibody reaction in idiopathic
thrombocytopenic purpura; though the evi-
dence suggests that an isoantibody to a plate-
let-foreign substance complex is responsible,
Other forms must be ruled out. The role of
SerOtOnin in pIatelet physiology remains to
be elucidated) and practical methods of plate-
let preservation and transfusion remain un-
discovered at this time.
I wi§h to express my gratitude to Drs. Edgar
E・ Baker and Matthew A. Derow’Of the Depart-
ment of Microbiology’Boston University School
Of Medicine) for their heIp in my understanding
Of the problems of platelet antibodies’ and to
Dr. CharIes P. Emerson, Of the Department of
Medicine’Massachus tts Memorial HospitaIs’for
his guidance in the preparation of this paper.
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THE TEST OF TIME
O豊霊霊謹嵩窪聖霊
years is the ever increaslng COmPlexity of
medical textbooks. It is no longer possible
for one author to cover the field of medicine
as a whole. Increasmg SPeCialization’With
more and more experts confining their atten-
tion to less and less of some small aspect of
medicine, has forced the textbook into the
fom of a collection of essays by many special-
ists. Usually a single editor tries to hold
the whole thing together and bring some
SOrt Of order and cohesion to a patchwork
Of papers of varying merit and style.
With this increase of knowledge more and
more hypothetical material is embodied in
the book and cIinical facts which have stood
the test of time are diluted with a welter of
unproved theories. If the book is intellectual輸
ly honest, these must be discussed and com_
Pared in some detail. The net result of all
this is that thc reader will be lしICky if at thc
Cnd of a chapter he has any idea at all what
thc author himse]f believes or llSeS in his
OWn daily PraCticc. Dogmatism is in dis-
re一〕ute’and to the student is left thc dcsl〕eratC
task of sifting the wheat from the cha任.
In this process no mental attitude is of
more value to him than one of scepticism・
Submerged by an ocean of new data, he
has∴SOmehow to distinguish the well-tried
and confimed, from the new and doubtful,
the hypotheticaI from the time proven. To
do this, he needs an ever present mood of
SCePticism. First’ he must approach the
medica=iterature with suspICIOn’VleWlng
and assesslng eaCh new paper with great
Care・ Who is the author? Where does he
WOrk? What is his past record? How great
is his experience? Are his results ade-
quately controIIed, his statistics valid, and his
COnClusions∴SOund? Secondly, the student
must apply the same sceptical attitude to thc
bedside teaching he receives) COnStantly wary
Of personal opinion poslng as fact. Every
teacher has his own pet theories and his
blind spots, and the student丘nds them skill_
fully blended with a modicum of truth.
“What is the evidence?’’is a question just
as necessary in the hospital as the law court.
Fact is for the classr∞m and opinion for
the cocktail party.
Nowhere is the scepticism more needed
than in assessing laboratory resuIts. The little
PleCe Of coIored paper with its deceptively
accurate looking figures has all the air of
re iability; and nothing is easier to forget
than the degree of experimental error lying
b hind it, tO Wh ch must be added the per-
SOnal error of the technician that may at
times occur. At i s best) the figure is a cIose
approximation and at its worst a misleading
falsity.
Yet the experienced clinical teacher who
is also dogmatic probably offers the student
his quickest way of achieving a base line of
knowledge in clinical medicine. Provided
Dr. X, the teacher言s exp〇rienced and wise,
he is lik ly to talk sense at least 50 per cent
Of the ti e; an the student, having leamed
What one man feels to be true and important,
Can PrOCeed to the other important task of
Checking his teacher’s statements on each
new patient he sees. In this way he builds up
his own reliable body of experienced knowl-
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edge. This is the classical method of clinical
education. Its success deponds on the scep-
ticism of the student and his ability to check
at the bedside in the future what he is told
there by his teacher today.
We have long believed that it would be
useful to persuade a series of experienced
clinical teachers in di任erent specialties to
record in print some of the clinical facts
which by long experience they have leamed
to be valid. They would confine themselves
to diagnostic or therapeutic material which
i綿‘heiγ Om e函eγieme has stood the test
of time. They would set down those clinical
modes of thought they use in their own
practice) Which have seldom if ever let them
down’and disregard any other opinion than
their own. Such a series of articles by teach-
ers of 珊erent specialties would supply a
nucleus of r liable rules which at any rate
would merit he close attention of the medi-
cal student and which he could test in prac-
tice in future years. By design these articles
would contain th  dogmatic statements of
on  man. This is the aim. As a nucleus of
t s able clinical dogma, the sceptical student
could hardly have a better clinical foundation
to work on.
We int nd, therefore, in the near future to
produce such a series of articles in the Bo∫-
ion Medical Qc/aγieγdy, Printing one article
in each issue. We hope our medical students
will v ew th m with a sceptical eye and test
their validity at the bedside・ We hope also
that they w ll survive the test of time.
LD.0.
ANNOUNCEMENTS
TRAINING PROGRAM FOR DENTAL
ASSISTANTS
A training program for dental assistants
is being offered to qua駈ed high school grad-
uates by the Boston University Medical Cen-
The year-long program will begin July
l’1963, and will include practical training
in the dental clinic of the Massachusetts
Memorial Hospitals as we11 as fomal classes
and laboratory work in all phases of dental
assistin g.
Lectures and classes include the following
subjects: development and anatomy of the
teeth’anatOmy Of the head) PhysioIogy and
histoIogy) dental pathoIogy) aneSthesia and
oral surgery) dental roentgenoIogy’ basic
laboratory technics) tOOth drawing and carv-
ing, dental instruments and materials’Sterili-
zation, Oral hygiene’diet and nutrition) Pub-
1ic health dentistry’dental ethics) Care and
operation of equipment and o鯖ce manage-
The program will be under the direction
of Dr. Henry M. Goldman and under the
supervision of Dr. Chester I. SoIomon・ The
tuition fee wi11 be $350.00. Further informa-
tion may be obtained by writing to the
Boston University Medical Center? 80 East
Concord Street, Boston 18, Massachusetts.
SARGENT COLLEGE DIVISION OF
OCCUPATIONAL THERAPY
The new Sargent Co11ege Division of Oc-
cupational Therapy) designed to train occu-
pational therapists and leaders vital to the
nation’s e任ort to strengthen its rehabilita-
tion program and restore increasmg numbers
of physically handicapped persons to voca-
tional us fulness’Will be inaugurated at Bos-
ton Un versity’s Sargent College in the fall
of 1963.
The new progr m will be designed to meet
the essentials for an approved school as set
forth by the Council on Medical Education
and Hospita s of the American Medical As-
sociation and is being prepared with the as-
sistance f the American Occupational Ther-
apy Association.
Miss Jerr  A. Johnson, Of Levelland, Tex-
as’P eSe tly a lieutenant in the United States
Navy Waves, W l become chaiman of the
Division. Miss Johnson received her Bachelor
of Science degree in Occupational Therapy
at Texas Wome ’s University in 1953.
APPOINTM ENT
Dr. Sidn y S. Ge11is) distinguished Boston
pediatrician-and professor) has been ap-
pointed Acting Dean of Boston University
SchooI of Medicine.
Pu blication∫
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Dr. Gellis has been professor of pediatrics
and Chaiman of the Department of Pedi-
atrics at Boston University since 1956. He
is also Director of Pediatrics at Boston City
Hospital.
Prior to his appomtment he was an in-
StruCtOr in pediatrics at Johns Hopkins SchooI
Of Medicine) aSSistant in pediatrics at Har-
Vard Medical School, Physician-in-Chief at
Children,s Hospital and pediatrician-in-Chief
at Beth Israel Hospital.
Dr. Gellis∴SuCCeeds Dr. Lamar Soutter’
Who remains professor of surgery.
ITEMS OF INTEREST
The Trustees of Boston University Medical
Center have authorized the engagement of
architects for preliminary plans and the de-
Velopment of related fund-raising programs
for new buildings which wiIl include the
foIIowing ‥
Basic Sciences Instructional BuiIding) With
teaching laboratories, Iecture rooms and of_
fices in a nine- Or ten-floor structure, tO be
located between the research building and
East Concord Street.
Health Services and Education Building
With ambulatory and other patient care’
home medical servICe’mStruCtional health
Service’industrial rehabilitation’emergenCy
treatment, Clinical research’Student and em-
PIoyee heaIth service’etC.’and possibly in-
VOIving reorganization and rea1location of
SPaCe uSe in the present hospitals. Site
Choices are yet to be made.
Residential (and Social and Eating) Facili-
ties, With quarters) Chiefly apartment-tyPe,
for medical and other students, aS Well as
house o鯖cers’nurSeS and ancillary personneI,
in one or more related buildings. They wilI
include areas for eating, a Center for social
activities and wi11 be financed through self-
amortizing federal loans) the applications for
Which are currently in process.
STUDY ON MATERNAL HEIGHT
AND PREVALENCE OF STILLBIRTHS
Dr. Jack B. Bresler, aSSOCiate professor of
bioIogy at Boston University’s Graduate
School and College of Liberal Arts’has
recently made a study on白Matemal Height
and the Prevalence of Stillbirths.・, The three_
year study, Which was conducted in the Provi_
dence Lying-in Hospital’WaS Published re-
Cently in the Ameγican /0“γnal of Physical
An勅γOpOlo糾,.
The study is based on an earlier one made
in Scotl nd by Professor Dugald Baird of
Aberdeen University.
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SEcONAL⑬ SOD8UM
PROVIDES RAPID SEDATION OF SHORT DURATlON
When ne「vous, eXCited, Or aPPrehensive patients can’t sleep, Seconai Sodium provides a 「apid
hypnotic effectfor a good night’s rest. ln recommended doses, SeconaI Sodium usua=y brings sIeep
Within冊een to thirty minutes and helps the patient cross the threshold of sieep gentIy and natu.
raiiy. SIeep, OnCe induced, genera=y continues throughout the night. Since the effect of Seconal
Sodium is dissipated within five to eight hours, the patient awakens refreshed and aiert, Without
the feeling of hangover.
UsuaI hypnotic dose: 1 1/2 grains (0.1 Gm.) at bedtime.　　　　seconal⑪ sodiUm (SeCOba「bitai sodium同iiy)
符鵠i艦嵩譜悪罵鱈2葦浩磐轟終年藍謹護岸霊3
disintegrating tablets, L用y),
ThiS iS a rem'=de「 advert-Sement. Fo′ adequate …(°…aliOn †o「 use, Piease consull manufacluJe'一s llteratUre. Ellしiiiy and
Company, indlanaPoilS 6, Incliana. 国
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F「om to「ture to relief
Ⅲ冊同軸即調案言
A,P.C. with Demeroi provides fast certain reIief
from pain. It is aIso miIdly sedating, antispas・
modic and antipyretic, In contrast to codeine and
morphine, A.P.C. with DemeroI does not constipate
and does not interfere with micturition.
Each A.P.C. with DemeroI tabIet contains 20O mg.
(3 grains) of aspirin, 150 mg. (2施grains) of
Phenacetin, 30 mg.偽grain) of caffeine, and
3O mg.陸grain) of Demerol (brand of meperidine)
hydrochioride.
The usual aduit dose is I or 2 tablets by mouth,
repeated, if necessary, at intervals of from three
to four hours.
oiM印○しくefl▲ND °p Mepe貫ioiN∈),丁鼠▲o∈動AR購`くらe. ∪・3・ pA↑・ o戸′・
A.P.C. with DemeroI hydrochloride is genera=y
We= toIerated, but with large doses dizziness may
OCCur-mOre COmmOnIy in ambuIatory patients.
Less often there may be nausea or vomiting.
FIushing of the face, SWeating, and dryness of
mouth are sometimes noted. Idiosyncrasies to any
Of the components ay occur, SuCh as alIergic
Pruritus, u面caria and sneezing. The tabIets may
be habit orming.
SuppIied in scored tabIets, bottIes of lOO and
lOOO. Narcotic bIank required.
Winthrop Labo atories, New York 18, N.Y.
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Not the doctors who
Carry Crosbie-MacDonald,s
Physicians’Liability I11SuranCe.
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PerSOnal attention by
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attorneys assures
immediate action and a
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liability problems.
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ASTHMA「
A CLÅ罵S耳銅昔N輔苗錦Å廿里の困封の配
HALDRON E⑩
(Pa「amethasone acetate,しi=y)
Haldrone produces rapid remission of the symptoms of asthma
and controIs the patient over extended periods with relative
freedom from side-e価ects・ In recommended dosage) Haldrone
is unlikely to cause sodium retention and has little or no e部ect
On POtaSSium excretion.
This is a 「eminder advertisement. For adequate
information for use, Please consuIt manufac-
tu「e「’s literature.郎L用y and Company. Indian・
apoIis 6, lndiana.　　　　　　　　　　　24O122
Suggesled daily dosage for asthma:
Initiaisuppressivedose . . . . . 6.12mg.
MainlenanCedose　. . . . . . .　2.6mg.
S pplied in boltles of 30, 100. and 500 1able[S:
2 mg., Orange (scored)
l mg.. Yel!owくscored)
???????
、
